Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: PI3K-Akt signaling pathway (mmu04151)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1110001D
15Rik
KLA  ATP  ATP+KLA
 NM_026763 RIKEN cDNA 1110001D15 gene (1110001D15Rik), mRNA [NM_026763] KLA 1.01 1.00 1.05 1.06 1.06 1.07 1.04
ATP 1.03 1.02 1.06 1.03 1.09 1.11 .95
KLA/ATP 1.04 1.02 1.07 1.05 1.01 1.06 1.04
3222402P
14Rik
KLA  ATP  ATP+KLA
 AK035077 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430084I02 product:SERINE/THREONINE PROTEIN PHOSPHATASE 2A, 72/130 KDA REGULATORY SUBUNIT B (PP2A, SUBUNIT B, B-PR72/PR130) KLA 1.06 .96 1.06 .93 .97 .96 .93
ATP .98 1.04 .93 .98 .95 1.10 .93
KLA/ATP 1.00 1.06 .91 .92 .99 .94 .95
3222402P
14Rik
KLA  ATP  ATP+KLA
 XM_001475836 gb|PREDICTED: Mus musculus RIKEN cDNA 3222402P14 gene (3222402P14Rik), mRNA [XM_001475836] KLA 1.38 1.32 1.26 1.05 .84 .83 .85
ATP 1.01 1.02 .93 .94 1.00 1.04 .87
KLA/ATP 1.37 1.47 1.01 .91 .86 .87 .75
4932417H
02Rik
KLA  ATP  ATP+KLA
 AK029341 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832440O09 product:Hypothetical ARM repeat structure containing protein, full insert sequence. [AK029341] KLA .90 .86 .81 .84 .93 .84 .93
ATP 1.00 1.06 1.02 .88 .93 .76 1.06
KLA/ATP .90 .86 .88 .79 .83 .80 .98
4932417H
02Rik
KLA  ATP  ATP+KLA
 NM_028898 RIKEN cDNA 4932417H02 gene (4932417H02Rik), mRNA [NM_028898] KLA .76 .72 .83 .63 .61 .68 .75
ATP .99 .95 .79 .76 .66 .62 1.47
KLA/ATP .78 .71 .56 .50 .39 .48 .89
AK044510
KLA  ATP  ATP+KLA
 AK044510 adult retina cDNA, RIKEN full-length enriched library, clone:A930017M14 product:laminin, alpha 1, full insert sequence. [AK044510] KLA .96 1.07 1.03 1.05 1.00 1.06 1.16
ATP 1.04 1.04 1.04 1.04 1.05 1.08 1.01
KLA/ATP .96 1.08 1.07 1.10 1.12 1.08 1.01
AK045366
KLA  ATP  ATP+KLA
 AK045366 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230107A03 product:unclassifiable, full insert sequence [AK045366] KLA .88 .80 .79 .86 .89 .97 1.07
ATP 1.21 1.67 2.40 3.50 2.58 1.29 1.12
KLA/ATP .97 .98 1.30 1.76 1.26 1.15 1.06
AK077928
KLA  ATP  ATP+KLA
 AK077928 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030447G09 product:unclassifiable, full insert sequence. [AK077928] KLA .94 .91 .95 .95 1.04 .95 .99
ATP 1.11 1.05 .97 .87 .98 .86 .91
KLA/ATP 1.01 1.05 .97 .89 .92 .92 .93
Akt1
KLA  ATP  ATP+KLA
 NM_009652 thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] KLA .80 .80 .75 .75 .71 .70 .82
ATP 1.00 1.02 .76 .85 .76 .68 .84
KLA/ATP .82 .80 .64 .68 .67 .61 .72
Akt2
KLA  ATP  ATP+KLA
 NM_007434 thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] KLA 1.45 1.49 1.81 1.61 1.83 1.17 .92
ATP 1.12 1.12 1.00 1.28 1.20 .94 1.06
KLA/ATP 1.48 1.70 1.69 1.58 1.57 1.32 1.27
Akt3
KLA  ATP  ATP+KLA
 NM_011785 thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] KLA 3.42 3.45 5.31 5.16 4.65 3.80 2.12
ATP 1.12 1.22 1.10 1.37 1.02 1.11 1.56
KLA/ATP 3.72 4.17 4.62 4.64 2.74 2.05 3.82
Angpt1
KLA  ATP  ATP+KLA
 NM_009640 angiopoietin 1 (Angpt1), mRNA [NM_009640] KLA 1.19 1.24 1.37 1.49 1.45 1.20 .99
ATP 1.02 1.05 1.03 1.05 1.04 1.01 1.06
KLA/ATP 1.21 1.23 1.33 1.36 1.30 1.21 1.07
Angpt2
KLA  ATP  ATP+KLA
 NM_007426 angiopoietin 2 (Angpt2), mRNA [NM_007426] KLA .22 .22 .18 .22 .31 1.11 2.43
ATP .93 .92 1.36 3.33 5.55 1.44 7.53
KLA/ATP .20 .20 .28 .54 1.94 2.41 6.55
Angpt4
KLA  ATP  ATP+KLA
 NM_009641 angiopoietin 4 (Angpt4), mRNA [NM_009641] KLA 1.01 .99 1.00 1.09 .96 .96 .88
ATP .98 .97 1.02 .95 1.02 1.01 .93
KLA/ATP .97 1.01 1.02 .96 .97 .93 .99
Atf2
KLA  ATP  ATP+KLA
 AK047405 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930056P03 product:activating transcription factor 2, full insert sequence. [AK047405] KLA 1.01 1.00 1.02 1.04 1.03 1.03 1.00
ATP .99 1.00 .95 1.01 1.04 .98 1.03
KLA/ATP 1.07 1.00 .98 .99 1.00 1.03 .93
Atf2
KLA  ATP  ATP+KLA
 NM_001025093 activating transcription factor 2 (Atf2), transcript variant 1, mRNA [NM_001025093] KLA 1.35 1.30 1.32 1.31 1.37 1.09 1.20
ATP 1.15 1.17 .99 1.11 1.22 1.39 1.28
KLA/ATP 1.38 1.42 1.21 1.28 1.17 1.33 1.69
Atf4
KLA  ATP  ATP+KLA
 NM_009716 activating transcription factor 4 (Atf4), mRNA [NM_009716] KLA .91 1.06 1.13 1.31 1.92 2.59 3.01
ATP 1.05 1.14 1.34 2.88 4.84 2.36 2.56
KLA/ATP 1.14 1.08 1.17 2.40 3.72 3.54 3.62
BB217526
KLA  ATP  ATP+KLA
 AK083592 9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030051F04 product:unclassifiable, full insert sequence [AK083592] KLA 1.53 1.19 1.21 1.15 1.61 1.14 .87
ATP 1.33 1.11 1.15 1.11 2.06 1.48 1.13
KLA/ATP 1.36 1.18 1.61 1.37 1.77 1.10 1.13
BC010335
KLA  ATP  ATP+KLA
 BC010335 fibronectin 1, mRNA (cDNA clone IMAGE:3156499), **** WARNING: chimeric clone ****. [BC010335] KLA .94 .88 1.01 .99 .95 .95 1.07
ATP 1.06 .98 1.20 1.30 1.07 .97 .97
KLA/ATP .93 1.00 1.07 1.20 1.02 .96 .94
Bad
KLA  ATP  ATP+KLA
 AK029400 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4833429M11 product:Bcl-associated death promoter, full insert sequence. [AK029400] KLA 1.15 1.22 1.26 1.31 1.40 1.67 1.59
ATP .95 1.06 1.12 1.06 .78 .89 1.27
KLA/ATP 1.25 1.39 1.33 1.29 1.11 .91 1.38
Bcl2
KLA  ATP  ATP+KLA
 NM_009741 B-cell leukemia/lymphoma 2 (Bcl2), transcript variant 1, mRNA [NM_009741] KLA .30 .26 .25 .25 .34 .38 .26
ATP .97 .89 1.50 1.04 .99 .29 .52
KLA/ATP .28 .26 .40 .33 .62 .29 .12
Bcl2
KLA  ATP  ATP+KLA
 NM_177410 B-cell leukemia/lymphoma 2 (Bcl2), transcript variant 2, mRNA [NM_177410] KLA .33 .33 .37 .42 .49 .46 .39
ATP 1.07 1.12 1.22 1.56 1.00 .38 .76
KLA/ATP .35 .34 .54 .89 .76 .36 .23
Bcl2l1
KLA  ATP  ATP+KLA
 NM_009743 Bcl2-like 1 (Bcl2l1), nuclear gene encoding mitochondrial protein, mRNA [NM_009743] KLA .99 1.02 1.10 1.16 1.27 .97 1.05
ATP 1.18 1.42 .81 1.26 1.51 .71 1.67
KLA/ATP 1.21 1.30 .66 1.15 1.31 1.17 1.59
Bcl2l11
KLA  ATP  ATP+KLA
 NM_207680 BCL2-like 11 (apoptosis facilitator) (Bcl2l11), transcript variant 1, mRNA [NM_207680] KLA 4.91 4.68 3.46 2.88 1.79 1.77 1.59
ATP 1.01 .98 1.30 5.07 4.70 5.53 5.58
KLA/ATP 4.37 4.96 3.92 6.27 5.05 5.10 16.45
Brca1
KLA  ATP  ATP+KLA
 NM_009764 breast cancer 1 (Brca1), mRNA [NM_009764] KLA .40 .41 .40 .41 .38 .50 .40
ATP 1.13 1.18 1.07 .94 .76 .45 .44
KLA/ATP .42 .38 .41 .47 .50 .68 .46
Casp9
KLA  ATP  ATP+KLA
 NM_015733 caspase 9 (Casp9), mRNA [NM_015733] KLA .31 .31 .40 .66 .89 1.19 .91
ATP .88 .77 .91 .59 .43 .75 .93
KLA/ATP .26 .26 .30 .28 .80 1.06 .97
Ccnd1
KLA  ATP  ATP+KLA
 S78355 gb|Cyl-1=cyclin D1 [mice, BALB/c, brain, mRNA, 3737 nt]. [S78355] KLA .24 .23 .23 .24 .29 .47 .17
ATP 1.02 1.02 .88 .80 .52 .10 .21
KLA/ATP .27 .23 .22 .24 .27 .25 .14
Ccnd2
KLA  ATP  ATP+KLA
 NM_009829 cyclin D2 (Ccnd2), mRNA [NM_009829] KLA 12.92 13.66 11.94 12.37 11.11 5.44 1.53
ATP .98 .75 .50 .57 1.24 2.83 .40
KLA/ATP 11.19 11.62 10.34 7.96 7.92 7.10 2.57
Ccnd3
KLA  ATP  ATP+KLA
 NM_007632 cyclin D3 (Ccnd3), transcript variant 1, mRNA [NM_007632] KLA .60 .65 .86 1.02 1.91 2.26 1.45
ATP 1.05 1.14 .89 1.20 .74 .76 .99
KLA/ATP .70 .67 .54 .83 .61 1.19 1.45
Ccne1
KLA  ATP  ATP+KLA
 NM_007633 cyclin E1 (Ccne1), mRNA [NM_007633] KLA 1.13 1.14 1.13 .78 .51 .69 .55
ATP .92 .94 1.09 .93 .75 .71 .47
KLA/ATP 1.13 1.17 1.45 1.24 1.33 1.50 .85
Ccne2
KLA  ATP  ATP+KLA
 NM_001037134 cyclin E2 (Ccne2), transcript variant 1, mRNA [NM_001037134] KLA .34 .35 .42 .36 .35 .36 .26
ATP 1.02 1.11 1.01 .82 .58 .38 .23
KLA/ATP .36 .34 .44 .43 .41 .40 .25
Cd19
KLA  ATP  ATP+KLA
 NM_009844 CD19 antigen (Cd19), mRNA [NM_009844] KLA 1.05 1.04 1.09 1.05 1.03 1.07 1.10
ATP 1.04 1.03 .99 1.07 .93 .97 .97
KLA/ATP 1.04 1.03 1.02 .97 1.01 1.00 1.08
Cdc37
KLA  ATP  ATP+KLA
 NM_016742 cell division cycle 37 homolog (S. cerevisiae) (Cdc37), mRNA [NM_016742] KLA 1.40 1.41 1.33 1.28 1.31 1.12 .92
ATP 1.02 1.12 1.05 1.34 1.07 .66 .76
KLA/ATP 1.42 1.45 1.40 1.72 1.35 1.01 .66
Cdk2
KLA  ATP  ATP+KLA
 NM_016756 cyclin-dependent kinase 2 (Cdk2), transcript variant 2, mRNA [NM_016756] KLA .68 .67 .62 .63 .60 .74 .73
ATP 1.02 1.14 .91 .92 .68 .71 .65
KLA/ATP .67 .64 .64 .64 .61 .74 .62
Cdk4
KLA  ATP  ATP+KLA
 NM_009870 cyclin-dependent kinase 4 (Cdk4), mRNA [NM_009870] KLA .66 .72 .65 .55 .46 .50 .71
ATP 1.03 1.02 .53 .65 .66 .63 .75
KLA/ATP .78 .61 .31 .42 .44 .62 .43
Cdk6
KLA  ATP  ATP+KLA
 AK030810 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830411I20 product:unclassifiable, full insert sequence [AK030810] KLA 1.05 .96 .67 .51 .48 .49 .45
ATP 1.02 .91 .78 .49 .50 .47 .44
KLA/ATP 1.01 .89 .65 .40 .36 .26 .49
Cdk6
KLA  ATP  ATP+KLA
 NM_009873 cyclin-dependent kinase 6 (Cdk6), mRNA [NM_009873] KLA 2.63 2.36 2.14 1.80 1.55 1.32 1.03
ATP 1.11 1.21 1.06 1.23 .94 1.30 2.08
KLA/ATP 2.58 2.69 2.24 2.25 1.38 .85 3.00
Cdkn1a
KLA  ATP  ATP+KLA
 NM_007669 cyclin-dependent kinase inhibitor 1A (P21) (Cdkn1a), transcript variant 1, mRNA [NM_007669] KLA 4.72 4.90 4.96 3.73 2.11 1.14 1.02
ATP 1.14 1.52 .95 1.69 1.47 2.21 .50
KLA/ATP 5.99 7.08 3.86 6.37 3.00 2.55 2.05
Cdkn1b
KLA  ATP  ATP+KLA
 NM_009875 cyclin-dependent kinase inhibitor 1B (Cdkn1b), mRNA [NM_009875] KLA .81 .84 .84 .91 .93 .88 .97
ATP .99 1.09 .97 1.06 1.48 .94 .91
KLA/ATP .83 .91 1.04 1.36 1.48 1.06 1.09
Chad
KLA  ATP  ATP+KLA
 NM_007689 chondroadherin (Chad), mRNA [NM_007689] KLA 1.34 1.32 1.36 1.26 1.27 1.30 1.31
ATP 1.03 .94 1.16 1.08 1.12 1.37 1.26
KLA/ATP 1.36 1.44 1.52 1.57 1.32 1.42 1.56
Chrm1
KLA  ATP  ATP+KLA
 NM_001112697 cholinergic receptor, muscarinic 1, CNS (Chrm1), transcript variant 1, mRNA [NM_001112697] KLA 1.12 .99 .97 1.09 .92 .91 .97
ATP .95 1.06 1.01 1.06 1.05 1.06 .99
KLA/ATP 1.00 .99 1.02 1.00 1.05 .95 1.01
Chrm2
KLA  ATP  ATP+KLA
 NM_203491 cholinergic receptor, muscarinic 2, cardiac (Chrm2), mRNA [NM_203491] KLA 1.03 1.05 .98 1.02 1.04 1.06 1.05
ATP 1.09 .94 1.08 1.06 .98 1.04 .97
KLA/ATP 1.01 1.05 .97 1.01 .98 1.07 .99
Chuk
KLA  ATP  ATP+KLA
 NM_007700 conserved helix-loop-helix ubiquitous kinase (Chuk), mRNA [NM_007700] KLA 1.32 1.42 1.41 1.17 1.32 1.22 1.40
ATP 1.22 1.30 1.18 .97 1.02 1.00 1.37
KLA/ATP 1.56 1.61 1.21 1.09 .83 .84 1.17
Col11a1
KLA  ATP  ATP+KLA
 AK021265 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530001D20 product:unclassifiable, full insert sequence. [AK021265] KLA 1.02 1.01 1.03 1.06 1.02 1.03 1.05
ATP .97 .92 1.02 .96 .93 1.11 1.00
KLA/ATP 1.01 .96 .97 1.00 1.04 .89 1.08
Col11a1
KLA  ATP  ATP+KLA
 NM_007729 collagen, type XI, alpha 1 (Col11a1), mRNA [NM_007729] KLA 1.06 1.06 1.10 1.05 1.07 1.01 1.09
ATP .97 .93 .95 1.03 .96 1.01 1.05
KLA/ATP 1.03 .98 1.02 1.02 .97 .99 1.05
Col11a2
KLA  ATP  ATP+KLA
 NM_009926 collagen, type XI, alpha 2 (Col11a2), mRNA [NM_009926] KLA 5.62 5.61 5.24 4.99 3.69 1.95 1.14
ATP .95 .95 1.17 1.59 1.73 1.28 1.12
KLA/ATP 5.25 5.62 6.37 5.73 4.79 2.22 1.39
Col1a1
KLA  ATP  ATP+KLA
 NM_007742 collagen, type I, alpha 1 (Col1a1), mRNA [NM_007742] KLA 1.13 1.10 1.22 1.18 1.04 1.15 1.09
ATP 1.03 1.00 1.34 1.48 1.11 1.13 1.11
KLA/ATP 1.13 1.29 1.47 1.77 1.38 1.33 1.13
Col1a2
KLA  ATP  ATP+KLA
 AK031577 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030456A07 product:procollagen, type I, alpha 2, full insert sequence. [AK031577] KLA .98 1.03 1.02 1.01 1.03 1.01 .90
ATP .97 .96 .96 1.00 .92 1.00 1.00
KLA/ATP .97 1.00 1.02 1.06 .96 .98 1.00
Col1a2
KLA  ATP  ATP+KLA
 NM_007743 collagen, type I, alpha 2 (Col1a2), mRNA [NM_007743] KLA 1.25 1.20 1.58 1.41 1.32 1.51 1.08
ATP .92 .97 1.50 1.66 1.38 1.23 1.14
KLA/ATP 1.35 1.46 2.19 2.47 1.99 1.64 1.36
Col24a1
KLA  ATP  ATP+KLA
 NM_027770 collagen, type XXIV, alpha 1 (Col24a1), mRNA [NM_027770] KLA .96 1.03 .95 .99 1.01 1.02 .98
ATP .98 1.03 1.04 1.04 .95 .99 1.00
KLA/ATP 1.04 .98 1.01 .99 1.01 .93 .96
Col27a1
KLA  ATP  ATP+KLA
 AK076297 0 day neonate skin cDNA, RIKEN full-length enriched library, clone:4632427K15 product:procollagen, type XXVII, alpha 1, full insert sequence. [AK076297] KLA 1.19 1.39 1.10 1.06 1.01 1.04 .96
ATP 1.00 .99 1.02 .99 1.01 1.06 1.08
KLA/ATP 1.23 1.26 1.12 1.10 1.12 .95 1.03
Col27a1
KLA  ATP  ATP+KLA
 NM_025685 collagen, type XXVII, alpha 1 (Col27a1), mRNA [NM_025685] KLA 3.10 3.05 2.89 1.86 1.37 1.14 1.16
ATP 1.02 1.00 1.10 1.22 1.24 1.15 1.12
KLA/ATP 3.43 3.57 2.62 1.99 1.42 1.23 1.24
Col2a1
KLA  ATP  ATP+KLA
 AK053784 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130308G17 product:unclassifiable, full insert sequence. [AK053784] KLA .95 .97 1.05 .93 .94 .94 .98
ATP .99 .91 .97 .87 .99 1.03 .93
KLA/ATP .95 1.05 .95 1.01 .97 .97 1.00
Col2a1
KLA  ATP  ATP+KLA
 NM_031163 collagen, type II, alpha 1 (Col2a1), transcript variant 1, mRNA [NM_031163] KLA 1.20 1.28 1.29 1.21 1.33 1.24 1.21
ATP .98 1.02 1.02 1.09 1.02 1.01 1.09
KLA/ATP 1.33 1.28 1.09 1.32 1.15 1.12 1.17
Col3a1
KLA  ATP  ATP+KLA
 AK031544 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030449K06 product:PROCOLLAGEN, TYPE III, ALPHA 1 (FRAGMENT) homolog [Mus musculus], full insert sequence. [AK031544] KLA 1.04 .95 1.01 1.04 1.04 1.03 .97
ATP 1.00 .98 1.02 1.00 1.03 1.00 .98
KLA/ATP 1.11 1.03 1.05 .90 .95 1.01 .97
Col3a1
KLA  ATP  ATP+KLA
 NM_009930 collagen, type III, alpha 1 (Col3a1), mRNA [NM_009930] KLA 1.06 1.08 1.02 .99 1.02 1.03 .99
ATP .97 1.01 1.07 1.01 .92 .94 .99
KLA/ATP .97 .99 1.09 1.11 .98 1.00 1.02
Col4a1
KLA  ATP  ATP+KLA
 NM_009931 collagen, type IV, alpha 1 (Col4a1), mRNA [NM_009931] KLA 1.13 1.19 1.12 1.09 1.04 .89 .90
ATP 1.01 1.17 1.02 1.04 .91 .89 .97
KLA/ATP 1.14 1.24 1.03 1.15 .95 .86 1.01
Col4a2
KLA  ATP  ATP+KLA
 NM_009932 collagen, type IV, alpha 2 (Col4a2), mRNA [NM_009932] KLA 1.30 1.45 1.54 1.40 1.71 1.71 2.12
ATP 1.09 1.07 .98 1.03 .92 1.21 1.42
KLA/ATP 1.45 1.53 1.24 1.29 1.16 1.57 3.31
Col4a3
KLA  ATP  ATP+KLA
 NM_007734 collagen, type IV, alpha 3 (Col4a3), mRNA [NM_007734] KLA 1.09 1.11 1.12 1.10 1.05 1.06 1.04
ATP 1.02 1.03 1.01 .99 1.01 1.07 1.07
KLA/ATP 1.04 1.13 1.01 1.09 1.02 .98 1.01
Col4a4
KLA  ATP  ATP+KLA
 NM_007735 collagen, type IV, alpha 4 (Col4a4), mRNA [NM_007735] KLA 1.35 1.29 1.33 1.39 1.30 1.18 .98
ATP 1.14 1.08 1.30 1.54 1.54 1.34 .93
KLA/ATP 1.37 1.41 1.70 1.88 1.67 1.29 1.19
Col4a5
KLA  ATP  ATP+KLA
 NM_007736 collagen, type IV, alpha 5 (Col4a5), mRNA [NM_007736] KLA 1.00 .95 .95 .82 .72 .58 .70
ATP 1.05 1.18 .98 .88 .56 .53 .57
KLA/ATP 1.04 1.05 .83 .82 .58 .49 .61
Col4a6
KLA  ATP  ATP+KLA
 NM_053185 collagen, type IV, alpha 6 (Col4a6), mRNA [NM_053185] KLA 1.06 1.04 1.00 1.07 .94 .93 .94
ATP .97 .96 1.18 1.10 1.07 1.04 .86
KLA/ATP 1.00 1.05 1.22 1.06 1.12 1.02 .93
Col5a1
KLA  ATP  ATP+KLA
 NM_015734 collagen, type V, alpha 1 (Col5a1), mRNA [NM_015734] KLA 1.00 .99 1.07 1.01 1.03 1.01 1.10
ATP 1.02 .98 1.02 1.07 .96 1.01 1.09
KLA/ATP 1.03 1.01 1.08 1.08 1.01 1.09 1.08
Col5a2
KLA  ATP  ATP+KLA
 NM_007737 collagen, type V, alpha 2 (Col5a2), mRNA [NM_007737] KLA .96 1.01 1.12 1.03 .99 .98 .90
ATP .99 1.06 1.05 1.10 .90 .98 1.06
KLA/ATP .95 1.01 1.05 1.11 1.07 1.04 1.14
Col5a3
KLA  ATP  ATP+KLA
 NM_016919 collagen, type V, alpha 3 (Col5a3), mRNA [NM_016919] KLA 1.33 1.48 1.48 1.47 1.45 1.31 1.08
ATP 1.06 1.02 1.08 1.06 1.07 1.35 1.48
KLA/ATP 1.42 1.50 1.42 1.45 1.27 1.32 1.37
Col6a1
KLA  ATP  ATP+KLA
 NM_009933 collagen, type VI, alpha 1 (Col6a1), mRNA [NM_009933] KLA 1.08 1.12 1.29 1.16 1.17 .96 1.03
ATP 1.05 1.03 1.01 1.07 .98 .96 .88
KLA/ATP 1.16 1.18 .92 1.17 1.01 .98 .92
Col6a2
KLA  ATP  ATP+KLA
 AK044870 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130009B12 product:procollagen, type VI, alpha 2, full insert sequence. [AK044870] KLA 1.06 1.00 .99 .96 .96 1.00 1.01
ATP .95 .95 .92 1.10 1.09 1.03 1.01
KLA/ATP 1.01 .97 .98 1.04 .98 1.04 .96
Col6a2
KLA  ATP  ATP+KLA
 NM_146007 collagen, type VI, alpha 2 (Col6a2), mRNA [NM_146007] KLA .94 1.06 1.00 1.07 1.05 1.04 1.00
ATP 1.01 .99 1.02 1.01 1.00 1.01 .98
KLA/ATP 1.01 .99 1.04 1.01 1.08 1.01 .95
Col6a3
KLA  ATP  ATP+KLA
 AF034136 collagen alpha3(VI) (Col6a3) mRNA, partial cds [AF034136] KLA .97 1.00 1.03 1.00 1.03 1.04 1.06
ATP 1.00 .93 1.00 1.01 1.07 .97 1.01
KLA/ATP 1.08 1.04 1.05 1.04 .99 1.10 1.02
Comp
KLA  ATP  ATP+KLA
 NM_016685 cartilage oligomeric matrix protein (Comp), mRNA [NM_016685] KLA 1.02 1.09 1.18 1.08 .96 1.12 .97
ATP .89 1.02 .97 .95 1.13 2.59 1.24
KLA/ATP 1.09 1.09 1.03 .98 1.60 2.02 1.15
Creb1
KLA  ATP  ATP+KLA
 NM_009952 cAMP responsive element binding protein 1 (Creb1), transcript variant B, mRNA [NM_009952] KLA 1.42 1.33 1.16 .99 .83 .97 .92
ATP .92 .91 1.18 1.38 1.51 1.02 .75
KLA/ATP 1.34 1.31 1.49 1.37 1.71 1.05 .93
Creb3
KLA  ATP  ATP+KLA
 NM_013497 cAMP responsive element binding protein 3 (Creb3), mRNA [NM_013497] KLA 1.21 1.21 1.23 1.53 1.77 1.77 1.31
ATP 1.02 1.03 .99 1.05 .82 .83 1.48
KLA/ATP 1.15 1.18 1.20 1.26 1.13 1.15 1.86
Creb3l1
KLA  ATP  ATP+KLA
 NM_011957 cAMP responsive element binding protein 3-like 1 (Creb3l1), mRNA [NM_011957] KLA 1.18 1.17 1.53 1.28 1.22 1.11 1.23
ATP 1.01 1.09 .98 1.17 1.22 1.01 1.15
KLA/ATP 1.22 1.29 1.08 1.34 1.14 1.36 1.12
Creb3l2
KLA  ATP  ATP+KLA
 AK082964 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530025K05 product:unclassifiable, full insert sequence [AK082964] KLA .44 .38 .37 .40 .45 .42 .47
ATP .90 .78 1.22 .79 .54 .46 .44
KLA/ATP .41 .41 .49 .43 .50 .51 .23
Creb3l2
KLA  ATP  ATP+KLA
 NM_178661 cAMP responsive element binding protein 3-like 2 (Creb3l2), mRNA [NM_178661] KLA .98 .87 .76 .98 1.03 .87 1.12
ATP 1.20 1.18 1.50 1.35 .86 1.32 1.50
KLA/ATP .98 1.04 1.15 1.05 .79 1.27 1.25
Creb3l3
KLA  ATP  ATP+KLA
 NM_145365 cAMP responsive element binding protein 3-like 3 (Creb3l3), mRNA [NM_145365] KLA .66 .75 .65 .85 1.04 1.44 1.73
ATP 1.02 .98 .97 1.09 .85 .69 1.11
KLA/ATP .70 .66 .71 .83 .80 .85 1.05
Creb3l4
KLA  ATP  ATP+KLA
 NM_030080 cAMP responsive element binding protein 3-like 4 (Creb3l4), mRNA [NM_030080] KLA 1.55 1.42 1.51 1.73 1.76 2.54 1.38
ATP 1.07 .81 .89 1.08 .94 1.08 1.08
KLA/ATP 1.44 1.38 1.44 1.25 1.30 1.26 2.24
Creb5
KLA  ATP  ATP+KLA
 AK051306 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130032G03 product:unclassifiable, full insert sequence. [AK051306] KLA 2.18 2.13 2.42 1.97 1.57 1.94 1.98
ATP 1.11 1.09 1.47 1.74 1.36 1.44 1.62
KLA/ATP 2.55 2.77 3.02 3.15 2.51 2.52 2.61
Creb5
KLA  ATP  ATP+KLA
 NM_172728 cAMP responsive element binding protein 5 (Creb5), mRNA [NM_172728] KLA 3.70 3.60 2.84 2.39 1.92 2.81 1.84
ATP .92 .89 1.19 1.93 1.51 1.55 1.44
KLA/ATP 3.16 3.51 4.33 5.35 5.78 3.23 3.03
Crebl1
KLA  ATP  ATP+KLA
 NM_017406 cAMP responsive element binding protein-like 1 (Crebl1), mRNA [NM_017406] KLA 1.22 1.30 1.32 1.34 1.51 1.52 1.75
ATP 1.13 1.32 1.16 1.66 1.06 .93 1.54
KLA/ATP 1.37 1.25 1.21 1.74 1.04 1.01 2.07
Crtc2
KLA  ATP  ATP+KLA
 NM_028881 CREB regulated transcription coactivator 2 (Crtc2), mRNA [NM_028881] KLA 1.86 1.66 1.48 1.25 1.49 1.36 1.51
ATP 1.21 1.19 1.14 2.17 2.30 1.65 1.39
KLA/ATP 1.98 1.95 1.74 2.87 2.33 1.79 2.04
Csf1
KLA  ATP  ATP+KLA
 NM_007778 colony stimulating factor 1 (macrophage) (Csf1), transcript variant 1, mRNA [NM_007778] KLA 18.44 16.94 15.74 12.71 7.63 6.20 2.51
ATP 1.04 1.22 4.90 14.80 12.10 10.26 6.73
KLA/ATP 16.93 18.17 20.56 19.41 18.03 15.99 12.59
Csf1r
KLA  ATP  ATP+KLA
 NM_001037859 colony stimulating factor 1 receptor (Csf1r), mRNA [NM_001037859] KLA .76 .81 .88 .67 .74 .78 .90
ATP 1.10 1.22 .88 1.10 .87 .78 1.28
KLA/ATP .97 .87 .63 .83 .51 .66 1.18
Csf3
KLA  ATP  ATP+KLA
 NM_009971 colony stimulating factor 3 (granulocyte) (Csf3), mRNA [NM_009971] KLA 1.44 1.56 2.06 2.25 2.97 1.58 1.55
ATP 1.04 1.05 1.14 2.18 4.85 7.52 1.83
KLA/ATP 1.54 1.93 2.57 4.75 3.85 3.95 7.39
Csf3r
KLA  ATP  ATP+KLA
 NM_007782 colony stimulating factor 3 receptor (granulocyte) (Csf3r), mRNA [NM_007782] KLA 4.44 4.65 6.62 6.79 9.58 9.08 7.39
ATP 1.27 1.26 1.06 1.43 1.13 1.07 1.28
KLA/ATP 5.07 5.53 4.84 7.70 3.86 3.49 7.22
Ddit4
KLA  ATP  ATP+KLA
 NM_029083 DNA-damage-inducible transcript 4 (Ddit4), mRNA [NM_029083] KLA .59 .59 .64 .70 .58 .59 .52
ATP .53 .36 2.78 7.00 6.68 12.80 1.34
KLA/ATP .53 .68 5.47 12.86 9.74 8.93 2.95
E330026B
02Rik
KLA  ATP  ATP+KLA
 NM_172927 RIKEN cDNA E330026B02 gene (E330026B02Rik), transcript variant 2, mRNA [NM_172927] KLA .94 .98 1.02 1.02 .97 1.05 .99
ATP .97 .94 .98 1.02 1.02 .99 1.02
KLA/ATP 1.01 .99 1.03 1.04 .96 .97 .94
EG629860
KLA  ATP  ATP+KLA
 M17953 gb|Mouse Ig rearranged H-chain V-region mRNA VJ1 [M17953] KLA .96 1.05 1.03 1.08 1.08 1.02 .98
ATP .97 .99 1.05 1.10 .95 .94 .91
KLA/ATP .96 .94 .97 1.04 .97 1.01 .89
Efna1
KLA  ATP  ATP+KLA
 NM_010107 ephrin A1 (Efna1), mRNA [NM_010107] KLA 1.04 .94 .87 .95 .96 .92 .89
ATP 1.01 1.04 .99 .93 .90 1.05 .94
KLA/ATP .84 .93 .99 .91 .91 .86 .90
Efna2
KLA  ATP  ATP+KLA
 NM_007909 ephrin A2 (Efna2), mRNA [NM_007909] KLA 2.64 2.43 2.68 2.06 1.56 1.06 .92
ATP 1.00 1.20 1.11 1.12 1.04 1.08 .94
KLA/ATP 2.21 2.52 2.57 2.28 1.62 1.40 1.15
Efna3
KLA  ATP  ATP+KLA
 AK020438 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430025D14 product:ephrin A3, full insert sequence. [AK020438] KLA .99 .98 .97 .96 .94 .98 .95
ATP .98 1.05 .98 .96 1.00 1.00 1.02
KLA/ATP 1.01 1.03 1.04 1.03 .99 1.04 .98
Efna4
KLA  ATP  ATP+KLA
 NM_007910 ephrin A4 (Efna4), mRNA [NM_007910] KLA 1.01 .99 1.01 1.01 1.05 1.07 1.02
ATP .99 .98 .98 1.04 .98 .99 1.01
KLA/ATP .97 1.00 1.06 .97 .86 1.04 1.02
Efna5
KLA  ATP  ATP+KLA
 NM_010109 ephrin A5 (Efna5), transcript variant 2, mRNA [NM_010109] KLA 1.04 1.09 1.05 .98 .96 1.02 .97
ATP .92 1.02 1.07 .99 1.00 1.09 1.04
KLA/ATP .95 .93 1.02 1.00 1.04 1.00 1.01
Efna5
KLA  ATP  ATP+KLA
 NM_207654 ephrin A5 (Efna5), transcript variant 1, mRNA [NM_207654] KLA .96 .99 1.07 1.05 1.04 1.06 1.10
ATP .97 .90 1.05 1.03 1.02 1.00 1.04
KLA/ATP 1.07 1.02 1.08 1.03 1.05 1.14 1.01
Egf
KLA  ATP  ATP+KLA
 NM_010113 epidermal growth factor (Egf), mRNA [NM_010113] KLA .89 .90 .81 .83 .83 .86 .92
ATP 1.03 1.03 .95 .84 .67 .79 .88
KLA/ATP .86 .86 .77 .77 .69 .78 .83
Egfr
KLA  ATP  ATP+KLA
 NM_007912 epidermal growth factor receptor (Egfr), transcript variant 2, mRNA [NM_007912] KLA 1.10 1.07 1.14 1.11 1.08 1.03 .90
ATP .99 1.00 1.04 .98 .97 1.15 1.14
KLA/ATP 1.07 1.10 1.16 1.08 1.01 .97 .94
Egfr
KLA  ATP  ATP+KLA
 NM_207655 epidermal growth factor receptor (Egfr), transcript variant 1, mRNA [NM_207655] KLA 1.57 1.44 1.47 1.31 .96 .92 .76
ATP .97 .93 1.10 1.00 1.41 2.97 .86
KLA/ATP 1.44 1.50 1.61 1.30 1.14 1.21 .82
Eif4b
KLA  ATP  ATP+KLA
 NM_145625 eukaryotic translation initiation factor 4B (Eif4b), mRNA [NM_145625] KLA .93 .95 .95 .80 .75 .73 .97
ATP 1.08 1.19 1.04 1.43 1.34 1.48 1.04
KLA/ATP 1.13 1.07 .93 1.10 .98 1.19 1.55
Eif4e
KLA  ATP  ATP+KLA
 NM_007917 eukaryotic translation initiation factor 4E (Eif4e), mRNA [NM_007917] KLA 1.22 1.06 .94 .97 .83 .85 1.18
ATP 1.00 1.01 1.27 1.27 2.61 2.08 .97
KLA/ATP .95 1.04 1.37 1.16 1.50 1.28 .73
Eif4e2
KLA  ATP  ATP+KLA
 NM_001039169 eukaryotic translation initiation factor 4E member 2 (Eif4e2), transcript variant 2, mRNA [NM_001039169] KLA 1.53 1.51 1.54 1.52 1.55 1.49 1.55
ATP 1.02 1.08 1.12 1.45 1.61 1.51 1.15
KLA/ATP 1.56 1.60 1.59 1.90 1.90 1.75 1.68
Eif4e2
KLA  ATP  ATP+KLA
 NM_023314 eukaryotic translation initiation factor 4E member 2 (Eif4e2), transcript variant 3, mRNA [NM_023314] KLA 1.42 1.40 1.43 1.35 1.58 1.65 1.42
ATP 1.06 1.06 1.04 .98 1.41 2.07 2.04
KLA/ATP 1.46 1.48 1.40 1.45 1.64 2.12 2.30
Eif4ebp1
KLA  ATP  ATP+KLA
 NM_007918 eukaryotic translation initiation factor 4E binding protein 1 (Eif4ebp1), mRNA [NM_007918] KLA .66 .64 .59 .67 .81 .97 .97
ATP .97 .94 1.10 1.05 1.99 1.60 .91
KLA/ATP .62 .61 .68 .68 1.50 1.24 .95
Epha2
KLA  ATP  ATP+KLA
 NM_010139 Eph receptor A2 (Epha2), mRNA [NM_010139] KLA .88 .76 .65 .75 .84 .89 .83
ATP 1.08 1.14 1.35 3.86 2.84 1.93 1.07
KLA/ATP .82 .84 .78 1.59 1.58 1.62 1.15
Epo
KLA  ATP  ATP+KLA
 NM_007942 erythropoietin (Epo), mRNA [NM_007942] KLA 1.00 1.05 1.08 1.01 1.03 1.08 1.04
ATP .95 .97 .97 1.04 1.02 .99 1.01
KLA/ATP 1.03 1.01 .97 1.00 1.00 1.10 1.00
Epor
KLA  ATP  ATP+KLA
 NM_010149 erythropoietin receptor (Epor), mRNA [NM_010149] KLA .57 .56 .59 .66 .59 .52 .36
ATP 1.06 1.01 1.00 .95 .73 .52 .40
KLA/ATP .57 .53 .70 .66 .72 .62 .34
F2r
KLA  ATP  ATP+KLA
 NM_010169 coagulation factor II (thrombin) receptor (F2r), mRNA [NM_010169] KLA 3.73 3.81 3.68 3.00 2.75 1.49 1.01
ATP .98 1.02 1.25 1.24 1.31 1.63 1.16
KLA/ATP 3.51 4.05 3.49 3.00 2.48 1.69 1.23
Fasl
KLA  ATP  ATP+KLA
 NM_010177 Fas ligand (TNF superfamily, member 6) (Fasl), mRNA [NM_010177] KLA 1.03 1.01 1.03 1.02 1.01 1.01 1.00
ATP 1.00 .99 1.04 1.21 1.18 1.20 1.01
KLA/ATP 1.00 1.02 1.07 1.16 1.18 1.23 1.00
Fgf1
KLA  ATP  ATP+KLA
 NM_010197 fibroblast growth factor 1 (Fgf1), mRNA [NM_010197] KLA 1.07 .99 .99 1.00 1.03 .97 .99
ATP 1.01 1.03 1.01 .95 .95 .98 .88
KLA/ATP 1.03 .99 .97 .99 .98 .94 1.01
Fgf10
KLA  ATP  ATP+KLA
 NM_008002 fibroblast growth factor 10 (Fgf10), mRNA [NM_008002] KLA .99 .98 1.02 1.00 1.02 1.02 1.02
ATP 1.03 1.02 1.00 1.00 1.00 .99 .99
KLA/ATP 1.01 1.00 1.04 .99 1.00 1.02 1.01
Fgf11
KLA  ATP  ATP+KLA
 BC066859 fibroblast growth factor 11, mRNA (cDNA clone MGC:76712 IMAGE:30101881), complete cds [BC066859] KLA .64 .61 .55 .58 .51 .48 .77
ATP 1.00 .96 .78 .78 .63 .44 .48
KLA/ATP .64 .63 .59 .56 .54 .42 .40
Fgf11
KLA  ATP  ATP+KLA
 NM_010198 fibroblast growth factor 11 (Fgf11), mRNA [NM_010198] KLA .99 1.02 1.05 1.04 1.01 1.03 1.07
ATP .95 1.02 1.02 1.07 .98 1.01 1.07
KLA/ATP 1.01 1.01 1.08 .96 .97 .95 1.01
Fgf12
KLA  ATP  ATP+KLA
 NM_183064 fibroblast growth factor 12 (Fgf12), transcript variant 1, mRNA [NM_183064] KLA .96 .97 1.05 .99 .97 1.01 1.01
ATP .93 .97 .97 .97 .99 .95 1.00
KLA/ATP 1.02 1.05 1.10 1.02 .95 1.01 .95
Fgf13
KLA  ATP  ATP+KLA
 NM_010200 fibroblast growth factor 13 (Fgf13), mRNA [NM_010200] KLA .91 .92 .93 .84 .77 .66 .75
ATP 1.09 1.14 1.03 1.11 1.06 .68 .78
KLA/ATP .98 1.02 .86 .90 .78 .70 .79
Fgf14
KLA  ATP  ATP+KLA
 NM_010201 fibroblast growth factor 14 (Fgf14), transcript variant 1, mRNA [NM_010201] KLA 1.04 1.05 1.02 1.04 1.03 1.05 1.03
ATP .99 1.08 1.04 1.00 .99 .98 1.04
KLA/ATP 1.00 1.00 1.08 1.00 1.04 1.01 1.03
Fgf14
KLA  ATP  ATP+KLA
 NM_207667 fibroblast growth factor 14 (Fgf14), transcript variant 2, mRNA [NM_207667] KLA 1.04 1.01 .98 .93 .96 .96 .97
ATP 1.04 1.10 .94 .87 1.03 .99 .96
KLA/ATP .86 .94 1.03 .89 1.00 .90 1.03
Fgf15
KLA  ATP  ATP+KLA
 NM_008003 fibroblast growth factor 15 (Fgf15), mRNA [NM_008003] KLA 1.00 1.00 .95 .98 .92 .96 1.01
ATP .99 1.01 .98 .98 .93 .95 .97
KLA/ATP .98 1.01 1.02 1.03 .97 .97 1.00
Fgf16
KLA  ATP  ATP+KLA
 NM_030614 fibroblast growth factor 16 (Fgf16), mRNA [NM_030614] KLA 1.00 .97 .99 1.02 1.04 .97 .97
ATP 1.02 .99 .99 1.02 1.12 1.01 1.02
KLA/ATP 1.06 1.02 .99 1.01 1.00 1.10 1.03
Fgf17
KLA  ATP  ATP+KLA
 NM_008004 fibroblast growth factor 17 (Fgf17), mRNA [NM_008004] KLA .97 1.03 .98 1.00 .97 .97 .86
ATP .99 .96 .99 .90 1.02 1.01 1.01
KLA/ATP .99 .91 1.08 .99 .99 .98 .99
Fgf18
KLA  ATP  ATP+KLA
 NM_008005 fibroblast growth factor 18 (Fgf18), mRNA [NM_008005] KLA 1.17 1.18 1.16 1.12 1.03 1.13 1.04
ATP .96 .98 2.47 12.57 2.76 1.56 1.03
KLA/ATP 1.01 1.15 2.33 10.13 2.80 1.79 1.02
Fgf2
KLA  ATP  ATP+KLA
 NM_008006 fibroblast growth factor 2 (Fgf2), mRNA [NM_008006] KLA 1.02 1.01 1.00 1.03 1.01 1.02 1.01
ATP .99 1.01 1.00 1.02 1.01 1.01 1.00
KLA/ATP 1.00 1.01 .98 1.01 1.02 1.03 1.01
Fgf20
KLA  ATP  ATP+KLA
 NM_030610 fibroblast growth factor 20 (Fgf20), mRNA [NM_030610] KLA .97 1.08 .99 1.00 .97 1.00 .97
ATP 1.03 .95 .97 1.05 .98 .97 1.00
KLA/ATP .99 .99 1.06 1.04 1.02 .92 .96
Fgf21
KLA  ATP  ATP+KLA
 NM_020013 fibroblast growth factor 21 (Fgf21), mRNA [NM_020013] KLA 1.02 1.03 .87 1.04 1.00 1.01 1.00
ATP 1.04 .97 1.00 1.02 .96 1.05 1.02
KLA/ATP 1.08 1.00 1.00 1.00 1.03 1.02 .99
Fgf22
KLA  ATP  ATP+KLA
 AK008922 adult male stomach cDNA, RIKEN full-length enriched library, clone:2210414E06 product:FIBROBLAST GROWTH FACTOR-22 PRECURSOR (FGF-22) homolog [Mus musculus], full insert sequence [AK008922] KLA .90 .94 .95 1.04 1.03 .94 .97
ATP 1.04 1.01 .98 .93 .93 .95 .88
KLA/ATP .98 .97 .97 1.01 .95 .92 .95
Fgf22
KLA  ATP  ATP+KLA
 NM_023304 fibroblast growth factor 22 (Fgf22), mRNA [NM_023304] KLA .99 .94 1.01 .95 .97 .89 .99
ATP 1.00 .95 1.00 .96 .97 .93 .98
KLA/ATP .91 1.00 1.01 .92 .95 .98 .97
Fgf23
KLA  ATP  ATP+KLA
 NM_022657 fibroblast growth factor 23 (Fgf23), mRNA [NM_022657] KLA 1.32 1.39 1.27 1.22 1.07 1.03 1.14
ATP .95 1.00 1.05 1.07 1.05 1.02 .96
KLA/ATP 1.32 1.39 1.37 1.22 1.01 1.00 .90
Fgf3
KLA  ATP  ATP+KLA
 NM_008007 fibroblast growth factor 3 (Fgf3), mRNA [NM_008007] KLA 1.03 1.05 1.00 .97 1.01 .98 .97
ATP 1.01 1.00 .97 1.03 .98 1.03 .97
KLA/ATP .98 1.00 1.01 1.03 1.03 1.00 .99
Fgf5
KLA  ATP  ATP+KLA
 NM_010203 fibroblast growth factor 5 (Fgf5), mRNA [NM_010203] KLA 1.02 1.02 1.00 1.03 .97 1.05 .99
ATP 1.02 1.00 1.03 .97 .99 .97 1.04
KLA/ATP 1.05 .92 1.01 1.00 1.11 .96 .97
Fgf6
KLA  ATP  ATP+KLA
 M92416 fibroblast growth factor (Fgf6) mRNA, 3 end [M92416] KLA 1.09 1.07 1.00 1.06 .97 1.01 .96
ATP 1.02 1.02 1.06 1.02 .93 .99 .98
KLA/ATP 1.04 .99 1.00 .99 1.00 1.00 1.03
Fgf6
KLA  ATP  ATP+KLA
 NM_010204 fibroblast growth factor 6 (Fgf6), mRNA [NM_010204] KLA 1.00 .96 1.06 .96 .96 1.00 .91
ATP .94 1.00 .89 .95 1.01 .92 1.00
KLA/ATP .99 1.06 1.06 .86 1.00 .95 1.00
Fgf7
KLA  ATP  ATP+KLA
 NM_008008 fibroblast growth factor 7 (Fgf7), mRNA [NM_008008] KLA 1.02 1.02 1.02 1.03 1.05 1.11 1.04
ATP 1.00 1.01 1.11 1.15 1.05 1.04 1.06
KLA/ATP .99 .96 .83 1.10 1.15 1.26 1.21
Fgf8
KLA  ATP  ATP+KLA
 BC048734 fibroblast growth factor 8, mRNA (cDNA clone MGC:59627 IMAGE:6513131), complete cds [BC048734] KLA .96 .95 1.03 .96 1.06 .97 .96
ATP 1.08 .94 1.07 1.10 1.00 .93 1.06
KLA/ATP 1.03 1.02 1.04 .96 1.04 .94 .94
Fgf8
KLA  ATP  ATP+KLA
 NM_010205 fibroblast growth factor 8 (Fgf8), mRNA [NM_010205] KLA 1.00 1.00 1.03 1.04 1.04 1.07 1.09
ATP 1.01 1.01 1.11 1.14 1.11 1.09 1.05
KLA/ATP 1.00 1.04 1.14 1.18 1.15 1.09 1.04
Fgf9
KLA  ATP  ATP+KLA
 NM_013518 fibroblast growth factor 9 (Fgf9), mRNA [NM_013518] KLA 1.04 1.07 1.07 1.12 .97 .96 .91
ATP 1.02 1.08 .98 1.00 .94 .99 .92
KLA/ATP 1.04 1.03 1.03 1.00 .93 .93 .89
Fgfr1
KLA  ATP  ATP+KLA
 M28998 gb|Mouse basic fibroblast growth factor receptor (bFGF-R) mRNA, complete cds. [M28998] KLA .82 .79 .73 .66 .50 .55 .65
ATP 1.01 1.08 .86 .90 1.29 1.24 1.52
KLA/ATP .85 .82 .71 .71 .63 .80 .85
Fgfr1
KLA  ATP  ATP+KLA
 NM_010206 fibroblast growth factor receptor 1 (Fgfr1), transcript variant 1, mRNA [NM_010206] KLA .92 .86 .73 .82 .79 .85 .84
ATP 1.01 1.06 .92 .92 1.18 1.02 1.22
KLA/ATP .83 .83 .79 .76 .83 .83 .92
Fgfr2
KLA  ATP  ATP+KLA
 NM_010207 fibroblast growth factor receptor 2 (Fgfr2), transcript variant 1, mRNA [NM_010207] KLA 1.01 .98 1.00 1.01 .98 1.00 .99
ATP 1.00 1.03 1.05 1.03 1.01 1.01 1.00
KLA/ATP 1.00 1.01 1.04 1.01 .99 1.02 1.03
Fgfr3
KLA  ATP  ATP+KLA
 NM_008010 fibroblast growth factor receptor 3 (Fgfr3), mRNA [NM_008010] KLA 1.09 1.15 1.05 1.10 1.02 1.05 1.12
ATP 1.05 .94 .98 .87 .91 .95 .92
KLA/ATP 1.13 1.11 1.10 .91 .92 .93 .92
Fgfr4
KLA  ATP  ATP+KLA
 AF127140 fibroblast growth factor receptor 4 splice variant 17b (Fgfr4) mRNA, partial cds. [AF127140] KLA .96 .97 1.06 .97 1.05 1.05 1.08
ATP 1.02 .98 1.07 1.23 1.15 1.18 1.31
KLA/ATP .91 1.02 1.08 1.16 1.07 1.05 1.23
Fgfr4
KLA  ATP  ATP+KLA
 NM_008011 fibroblast growth factor receptor 4 (Fgfr4), mRNA [NM_008011] KLA 1.08 1.11 1.09 1.06 .99 1.06 1.03
ATP 1.05 .96 1.17 1.06 1.10 1.04 1.01
KLA/ATP 1.03 .98 1.10 1.06 1.05 1.06 1.04
Figf
KLA  ATP  ATP+KLA
 NM_010216 c-fos induced growth factor (Figf), mRNA [NM_010216] KLA .92 .95 .93 .87 .82 .87 .77
ATP 1.03 1.04 1.06 .90 1.13 2.02 .78
KLA/ATP .92 .94 .97 .85 .97 1.10 .92
Flt1
KLA  ATP  ATP+KLA
 NM_010228 FMS-like tyrosine kinase 1 (Flt1), mRNA [NM_010228] KLA 3.02 2.74 2.92 3.54 3.71 3.82 1.43
ATP .88 .85 1.07 .85 .94 1.31 1.16
KLA/ATP 2.60 2.99 3.08 2.13 2.23 2.00 2.59
Flt4
KLA  ATP  ATP+KLA
 NM_008029 FMS-like tyrosine kinase 4 (Flt4), mRNA [NM_008029] KLA 1.04 1.02 1.01 1.00 1.10 1.01 1.01
ATP 1.02 1.08 1.07 .99 .95 .97 1.02
KLA/ATP 1.08 1.06 1.00 1.02 .99 1.07 1.02
Fn1
KLA  ATP  ATP+KLA
 NM_010233 fibronectin 1 (Fn1), mRNA [NM_010233] KLA 1.23 1.30 1.38 1.12 1.16 1.00 .78
ATP 1.02 1.19 1.25 1.56 1.33 1.05 .95
KLA/ATP 1.36 1.51 1.34 1.70 1.20 1.06 .93
Foxo3a
KLA  ATP  ATP+KLA
 AK079567 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230087I01 product:unclassifiable, full insert sequence. [AK079567] KLA .82 .81 .91 .83 .86 .86 .81
ATP .98 1.00 1.13 1.03 .97 .90 .82
KLA/ATP .86 .80 .90 .99 1.07 .84 .73
Foxo3a
KLA  ATP  ATP+KLA
 NM_019740 forkhead box O3a (Foxo3a), mRNA [NM_019740] KLA .94 .92 .86 .97 .87 1.04 1.04
ATP .99 1.09 1.06 .97 .96 1.07 1.15
KLA/ATP .90 .79 .90 .99 .95 1.04 1.11
Frap1
KLA  ATP  ATP+KLA
 NM_020009 FK506 binding protein 12-rapamycin associated protein 1 (Frap1), mRNA [NM_020009] KLA 1.37 1.32 1.46 1.57 1.83 1.29 1.28
ATP 1.12 1.07 .95 .91 .80 .77 1.03
KLA/ATP 1.45 1.51 1.50 1.11 .89 .87 1.01
G6pc
KLA  ATP  ATP+KLA
 NM_008061 glucose-6-phosphatase, catalytic (G6pc), mRNA [NM_008061] KLA .96 .94 1.04 1.07 1.09 1.06 1.02
ATP .98 1.05 1.09 1.04 1.05 1.00 1.01
KLA/ATP 1.03 1.05 1.06 .96 1.02 1.00 .99
G6pc2
KLA  ATP  ATP+KLA
 NM_021331 glucose-6-phosphatase, catalytic, 2 (G6pc2), mRNA [NM_021331] KLA .99 1.03 1.00 .98 .95 1.02 .98
ATP .95 1.06 .97 1.08 1.16 1.26 1.04
KLA/ATP .94 .99 1.05 6.99 3.55 1.48 1.11
G6pc3
KLA  ATP  ATP+KLA
 NM_175935 glucose 6 phosphatase, catalytic, 3 (G6pc3), mRNA [NM_175935] KLA .88 .89 .89 .80 .75 .68 .88
ATP .99 1.05 .95 1.14 .92 .64 .81
KLA/ATP .92 .90 .79 .94 .70 .62 .58
Gbl
KLA  ATP  ATP+KLA
 NM_019988 G protein beta subunit-like (Gbl), mRNA [NM_019988] KLA .43 .37 .36 .45 .56 .77 1.10
ATP .94 .79 .71 .49 .56 1.42 .90
KLA/ATP .40 .37 .35 .29 .49 1.30 .86
Gh
KLA  ATP  ATP+KLA
 NM_008117 growth hormone (Gh), mRNA [NM_008117] KLA 1.02 1.03 1.01 .98 .98 .94 .98
ATP .94 1.02 1.06 1.20 .99 .95 .96
KLA/ATP .97 1.03 1.03 1.09 .96 1.00 1.05
Ghr
KLA  ATP  ATP+KLA
 AK053579 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130111P21 product:growth hormone receptor, full insert sequence. [AK053579] KLA 1.10 1.07 1.09 1.01 1.03 .96 1.02
ATP 1.04 1.01 1.06 .96 1.03 .96 1.02
KLA/ATP 1.08 1.15 1.15 1.04 1.02 1.07 1.03
Ghr
KLA  ATP  ATP+KLA
 NM_010284 growth hormone receptor (Ghr), transcript variant 1, mRNA [NM_010284] KLA 1.09 1.10 1.29 1.31 1.23 1.09 .97
ATP 1.00 1.02 1.03 1.02 .93 .96 .97
KLA/ATP 1.17 1.20 1.15 1.15 1.07 .96 .96
Gnb1
KLA  ATP  ATP+KLA
 NM_008142 guanine nucleotide binding protein (G protein), beta 1 (Gnb1), mRNA [NM_008142] KLA 1.11 1.18 1.22 1.19 1.29 1.32 1.76
ATP 1.02 1.09 .84 .99 .97 .89 1.22
KLA/ATP 1.20 1.25 .85 1.01 .86 .91 1.57
Gnb2
KLA  ATP  ATP+KLA
 NM_010312 guanine nucleotide binding protein (G protein), beta 2 (Gnb2), mRNA [NM_010312] KLA .94 .98 .94 1.08 1.23 1.32 1.16
ATP 1.04 .96 .59 .64 .59 .76 1.18
KLA/ATP 1.02 .84 .62 .64 .61 .89 1.36
Gnb3
KLA  ATP  ATP+KLA
 NM_013530 guanine nucleotide binding protein (G protein), beta 3 (Gnb3), mRNA [NM_013530] KLA .99 1.00 .98 1.03 .94 .99 .96
ATP 1.01 1.02 .97 .95 1.01 .97 .92
KLA/ATP .99 1.02 1.02 .98 .99 .85 .99
Gnb4
KLA  ATP  ATP+KLA
 AK165084 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330002E21 product:guanine nucleotide binding protein, beta 4, full insert sequence [AK165084] KLA 4.61 4.10 4.23 2.41 2.25 1.59 .93
ATP 1.21 1.17 1.04 .81 2.92 1.50 1.03
KLA/ATP 5.86 6.56 3.60 1.68 5.62 3.00 1.37
Gnb4
KLA  ATP  ATP+KLA
 NM_013531 guanine nucleotide binding protein (G protein), beta 4 (Gnb4), mRNA [NM_013531] KLA 8.41 8.09 10.57 9.44 6.06 2.97 .92
ATP 1.07 1.04 1.09 .87 1.48 2.10 1.18
KLA/ATP 8.14 8.93 9.12 7.69 5.03 5.11 2.37
Gnb5
KLA  ATP  ATP+KLA
 NM_010313 guanine nucleotide binding protein (G protein), beta 5 (Gnb5), transcript variant 1, mRNA [NM_010313] KLA .68 .75 .67 .66 .53 .50 .65
ATP 1.03 1.08 1.09 1.14 .72 .54 .77
KLA/ATP .73 .70 .71 .73 .61 .65 .58
Gng10
KLA  ATP  ATP+KLA
 NM_025277 guanine nucleotide binding protein (G protein), gamma 10 (Gng10), mRNA [NM_025277] KLA .95 .95 .86 .83 .70 .53 .43
ATP .93 1.03 1.17 1.21 .97 .60 .52
KLA/ATP .84 .91 .93 .99 .79 .47 .24
Gng11
KLA  ATP  ATP+KLA
 NM_025331 guanine nucleotide binding protein (G protein), gamma 11 (Gng11), mRNA [NM_025331] KLA 1.30 1.26 1.44 1.54 1.26 1.42 1.90
ATP .88 .78 1.26 1.14 .90 .64 1.60
KLA/ATP 1.11 1.18 1.81 1.55 1.81 1.75 3.05
Gng12
KLA  ATP  ATP+KLA
 NM_025278 guanine nucleotide binding protein (G protein), gamma 12 (Gng12), mRNA [NM_025278] KLA 2.21 2.23 2.48 2.62 2.47 2.28 1.68
ATP 1.02 1.02 1.09 1.10 1.20 1.32 1.01
KLA/ATP 2.10 2.17 2.38 2.40 1.91 1.60 1.77
Gng13
KLA  ATP  ATP+KLA
 NM_022422 guanine nucleotide binding protein (G protein), gamma 13 (Gng13), mRNA [NM_022422] KLA 1.04 1.04 .94 1.00 1.00 1.05 .96
ATP 1.07 1.05 1.02 .94 .98 1.03 1.01
KLA/ATP 1.01 .99 1.05 1.01 1.01 .98 1.02
Gng2
KLA  ATP  ATP+KLA
 NM_010315 guanine nucleotide binding protein (G protein), gamma 2 (Gng2), transcript variant 1, mRNA [NM_010315] KLA .79 .81 .81 .82 .67 .57 .75
ATP 1.02 1.01 1.13 1.35 1.48 1.01 1.31
KLA/ATP .79 .86 .97 1.05 1.29 1.00 .84
Gng3
KLA  ATP  ATP+KLA
 NM_010316 guanine nucleotide binding protein (G protein), gamma 3 (Gng3), mRNA [NM_010316] KLA 1.00 .98 1.02 .95 .99 1.00 1.06
ATP .98 1.05 .99 1.03 1.05 1.03 .97
KLA/ATP 1.01 1.00 1.07 1.01 1.04 1.04 1.05
Gng4
KLA  ATP  ATP+KLA
 NM_010317 guanine nucleotide binding protein (G protein), gamma 4 (Gng4), mRNA [NM_010317] KLA 1.27 1.26 1.47 1.30 1.15 1.13 .82
ATP 1.05 .97 1.07 1.62 3.97 3.46 1.24
KLA/ATP 1.35 1.32 1.37 1.35 1.64 2.18 1.56
Gng5
KLA  ATP  ATP+KLA
 NM_010318 guanine nucleotide binding protein (G protein), gamma 5 (Gng5), mRNA [NM_010318] KLA .94 .84 .80 1.12 .98 1.11 1.29
ATP 1.07 1.01 1.07 1.05 1.17 1.52 1.01
KLA/ATP .83 .94 1.27 1.17 1.19 1.35 1.36
Gng7
KLA  ATP  ATP+KLA
 NM_001038655 guanine nucleotide binding protein (G protein), gamma 7 (Gng7), transcript variant 1, mRNA [NM_001038655] KLA .92 .96 .87 .91 .83 .98 .98
ATP 1.04 1.06 .98 .95 .81 .77 .75
KLA/ATP .97 .95 .81 .91 .79 .77 .81
Gng8
KLA  ATP  ATP+KLA
 NM_010320 guanine nucleotide binding protein (G protein), gamma 8 (Gng8), mRNA [NM_010320] KLA .93 .93 .95 .96 .90 .88 1.09
ATP .95 .90 1.01 .92 1.04 1.01 1.05
KLA/ATP .97 1.03 .99 .90 1.10 .99 1.04
Gngt1
KLA  ATP  ATP+KLA
 NM_010314 guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 (Gngt1), mRNA [NM_010314] KLA 1.06 .99 .95 .98 1.03 1.10 .98
ATP .96 1.02 1.03 1.03 .94 1.06 .95
KLA/ATP .98 1.03 1.04 1.04 1.01 1.03 1.01
Grb2
KLA  ATP  ATP+KLA
 NM_008163 growth factor receptor bound protein 2 (Grb2), mRNA [NM_008163] KLA .92 .88 .90 1.27 1.43 1.22 1.00
ATP 1.02 .83 .51 .42 .92 .70 .57
KLA/ATP .84 .77 .61 .56 1.56 1.49 .52
Grb2
KLA  ATP  ATP+KLA
 U07617 Grb2 adaptor protein (grb2) mRNA, complete cds. [U07617] KLA .83 .80 .95 1.13 1.38 1.36 1.06
ATP .84 .74 .51 .41 .82 .74 .59
KLA/ATP .77 .70 .57 .54 1.49 1.39 .53
Gsk3b
KLA  ATP  ATP+KLA
 NM_019827 glycogen synthase kinase 3 beta (Gsk3b), mRNA [NM_019827] KLA 1.06 1.03 1.11 1.01 1.26 1.28 1.26
ATP 1.18 1.27 1.15 2.07 2.37 2.32 1.67
KLA/ATP 1.15 1.21 .98 1.50 1.67 2.50 2.99
Gys1
KLA  ATP  ATP+KLA
 NM_030678 glycogen synthase 1, muscle (Gys1), mRNA [NM_030678] KLA .89 .89 .88 .80 .91 1.07 1.78
ATP 1.02 1.15 .91 1.01 .72 .73 1.14
KLA/ATP .96 .94 .73 .87 .63 .64 1.24
Gys2
KLA  ATP  ATP+KLA
 NM_145572 glycogen synthase 2 (Gys2), mRNA [NM_145572] KLA 1.01 .96 .99 1.06 1.02 1.00 .92
ATP .99 .98 .98 1.02 .95 1.12 1.10
KLA/ATP 1.03 .97 1.00 1.03 1.01 1.05 1.09
Hgf
KLA  ATP  ATP+KLA
 AK033274 15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030481P22 product:inferred: hepatocyte growth factor [AK033274] KLA 1.34 1.22 .96 .93 .82 .93 .87
ATP 1.64 2.45 3.30 1.89 .97 1.12 .90
KLA/ATP 1.49 2.50 3.96 1.88 1.07 1.00 .83
Hgf
KLA  ATP  ATP+KLA
 NM_010427 hepatocyte growth factor (Hgf), mRNA [NM_010427] KLA 1.11 1.18 1.30 1.20 1.08 .96 1.14
ATP 1.02 1.14 1.32 1.62 1.17 1.26 1.47
KLA/ATP 1.18 1.24 1.33 1.84 1.19 1.09 1.31
Hras1
KLA  ATP  ATP+KLA
 NM_008284 Harvey rat sarcoma virus oncogene 1 (Hras1), mRNA [NM_008284] KLA .79 .82 .77 .82 .94 1.03 1.07
ATP 1.01 .95 .69 .83 .79 1.12 1.15
KLA/ATP .84 .77 .61 .65 .82 1.00 1.05
Hsp90aa1
KLA  ATP  ATP+KLA
 NM_010480 heat shock protein 90, alpha (cytosolic), class A member 1 (Hsp90aa1), mRNA [NM_010480] KLA .95 1.03 .90 .92 .80 .94 .99
ATP .96 .92 1.39 1.21 2.02 3.66 1.10
KLA/ATP .93 .92 1.32 1.01 1.85 2.21 1.20
Hsp90ab1
KLA  ATP  ATP+KLA
 NM_008302 heat shock protein 90kDa alpha (cytosolic), class B member 1 (Hsp90ab1), mRNA [NM_008302] KLA .93 1.02 .98 .82 .95 1.10 1.39
ATP 1.04 1.14 .92 1.32 1.19 1.02 .63
KLA/ATP 1.02 1.04 .80 1.12 .87 .86 .75
Hsp90b1
KLA  ATP  ATP+KLA
 NM_011631 heat shock protein 90, beta (Grp94), member 1 (Hsp90b1), mRNA [NM_011631] KLA .78 .83 .71 .69 .73 .69 .80
ATP 1.00 1.08 1.01 .94 .84 .84 .66
KLA/ATP .78 .82 .81 .73 .66 .68 .27
Ibsp
KLA  ATP  ATP+KLA
 NM_008318 integrin binding sialoprotein (Ibsp), mRNA [NM_008318] KLA .99 1.02 1.05 .96 .98 .96 .97
ATP .98 .99 .99 .96 1.00 1.02 1.00
KLA/ATP 1.01 1.07 1.03 .93 .93 .95 .95
Ifna12
KLA  ATP  ATP+KLA
 NM_177361 interferon alpha 12 (Ifna12), mRNA [NM_177361] KLA 1.25 1.26 1.34 1.16 1.06 1.10 1.09
ATP 1.01 .97 1.07 1.09 1.17 1.20 1.07
KLA/ATP 1.12 1.29 1.72 1.54 1.59 1.56 1.05
Ifna13
KLA  ATP  ATP+KLA
 NM_177347 interferon alpha 13 (Ifna13), mRNA [NM_177347] KLA 1.32 1.27 1.26 1.34 1.15 1.24 1.20
ATP .95 1.08 1.29 1.79 1.41 1.22 1.08
KLA/ATP 1.36 1.35 2.04 2.81 2.07 1.44 1.19
Ifna2
KLA  ATP  ATP+KLA
 K01411 gb|Mouse alpha-interferon (MuIFN-alpha), 3 cds & untranslated mRNA [K01411] KLA 1.02 1.03 1.10 .96 .93 .99 1.01
ATP 1.02 .98 1.00 .98 1.02 .97 .95
KLA/ATP 1.02 1.04 1.18 1.08 1.13 1.04 1.01
Ifna2
KLA  ATP  ATP+KLA
 NM_010503 interferon alpha 2 (Ifna2), mRNA [NM_010503] KLA 1.08 1.06 1.07 1.06 .98 1.02 1.05
ATP .94 1.06 1.11 1.30 1.24 1.25 1.21
KLA/ATP 1.03 1.20 1.19 1.35 1.52 1.60 1.18
Ifna4
KLA  ATP  ATP+KLA
 NM_010504 interferon alpha 4 (Ifna4), mRNA [NM_010504] KLA .99 1.04 1.05 .97 1.00 .96 .99
ATP 1.01 .96 .98 1.01 1.00 1.00 .97
KLA/ATP 1.10 1.09 1.05 1.04 1.01 .97 1.01
Ifna5
KLA  ATP  ATP+KLA
 NM_010505 interferon alpha 5 (Ifna5), mRNA [NM_010505] KLA 1.15 1.23 1.51 1.26 1.03 1.06 1.05
ATP .99 .94 1.11 1.00 1.09 1.07 1.03
KLA/ATP 1.12 1.29 1.46 1.47 1.24 1.32 1.03
Ifna9
KLA  ATP  ATP+KLA
 NM_010507 interferon alpha 9 (Ifna9), mRNA [NM_010507] KLA 1.05 1.09 1.20 1.06 1.08 1.06 1.02
ATP .99 1.08 1.18 1.21 1.09 .99 .97
KLA/ATP 1.09 1.23 1.19 1.24 1.18 1.16 1.04
Ifnab
KLA  ATP  ATP+KLA
 BC116864 interferon alpha B, mRNA (cDNA clone MGC:151241 IMAGE:40126183), complete cds [BC116864] KLA 1.20 1.33 1.29 1.30 1.20 1.20 1.08
ATP .99 .99 1.00 1.25 1.13 1.19 1.04
KLA/ATP 1.30 1.39 1.44 1.48 1.49 1.54 1.22
Ifnar1
KLA  ATP  ATP+KLA
 NM_010508 interferon (alpha and beta) receptor 1 (Ifnar1), mRNA [NM_010508] KLA 1.35 1.29 1.19 1.39 1.60 1.47 1.49
ATP 1.18 1.25 .94 1.06 1.07 1.48 1.52
KLA/ATP 1.56 1.57 .98 1.43 1.08 1.79 3.54
Ifnar2
KLA  ATP  ATP+KLA
 NM_010509 interferon (alpha and beta) receptor 2 (Ifnar2), transcript variant 1, mRNA [NM_010509] KLA 1.45 1.43 1.67 1.87 2.31 1.84 1.36
ATP .99 .92 .87 1.03 1.38 1.79 1.43
KLA/ATP 1.48 1.48 1.24 1.54 1.77 2.10 2.81
Ifnb1
KLA  ATP  ATP+KLA
 NM_010510 interferon beta 1, fibroblast (Ifnb1), mRNA [NM_010510] KLA 49.82 46.57 34.05 16.05 5.94 7.31 8.49
ATP .99 1.02 1.89 4.78 6.31 4.44 1.79
KLA/ATP 49.22 61.83 134.08 144.05 110.96 31.78 11.24
Igf1
KLA  ATP  ATP+KLA
 AK050118 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730016P09 product:unclassifiable, full insert sequence. [AK050118] KLA .13 .14 .15 .16 .22 .34 .48
ATP 1.78 2.05 1.37 .72 .34 .41 .58
KLA/ATP .24 .45 .50 .24 .20 .26 .68
Igf1
KLA  ATP  ATP+KLA
 NM_010512 insulin-like growth factor 1 (Igf1), transcript variant 1, mRNA [NM_010512] KLA .84 .78 .76 .67 .54 .48 .59
ATP .97 .98 1.13 1.13 1.03 .88 .89
KLA/ATP .82 .81 .93 .86 .83 .65 .89
Igf1
KLA  ATP  ATP+KLA
 NM_184052 insulin-like growth factor 1 (Igf1), transcript variant 2, mRNA [NM_184052] KLA .77 .82 .76 .65 .60 .52 .69
ATP 1.01 1.07 .98 1.06 1.03 .78 .94
KLA/ATP .89 .86 .77 .80 .75 .65 .89
Igf1r
KLA  ATP  ATP+KLA
 NM_010513 insulin-like growth factor I receptor (Igf1r), mRNA [NM_010513] KLA 1.32 1.32 1.08 .91 .55 .48 .45
ATP 1.03 1.06 1.06 1.29 1.31 1.45 .47
KLA/ATP 1.30 1.37 1.11 1.00 .93 1.02 .45
Igh-VJ55
8
KLA  ATP  ATP+KLA
 AY547436 immunoglobulin heavy chain VDJ region mRNA, partial cds [AY547436] KLA 1.06 1.05 1.01 .93 1.03 .96 .93
ATP .99 1.00 1.06 .95 .96 1.06 1.05
KLA/ATP .98 .94 1.07 .95 .97 .99 1.02
Igh-VJ55
8
KLA  ATP  ATP+KLA
 CA578712 gb|K0727F04-5N NIA Mouse Hematopoietic Stem Cell (Lin- [CA578712] KLA .99 .94 1.01 1.10 .93 .97 .92
ATP .93 1.04 1.01 .98 1.05 .96 .95
KLA/ATP .99 .95 .95 .98 1.02 .98 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103412 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHA] [ENSMUST00000103412] KLA 1.01 .97 1.20 1.01 .98 1.44 1.24
ATP .99 .98 1.07 1.03 1.00 1.01 1.21
KLA/ATP .99 1.02 .96 1.03 .97 1.13 1.30
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103413 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHE] [ENSMUST00000103413] KLA 1.00 .99 1.06 1.06 .99 1.03 1.02
ATP 1.08 1.06 1.06 1.06 1.02 1.06 .95
KLA/ATP 1.00 1.04 1.09 1.02 1.06 1.02 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 U39781 J558+ IgM heavy chain mRNA, hybridoma clone ME2B7, partial cds. [U39781] KLA .93 .89 .98 .97 1.03 1.00 .94
ATP 1.04 1.02 1.08 .94 .93 .90 .79
KLA/ATP .88 .89 .97 .93 .88 .92 .82
Ikbkb
KLA  ATP  ATP+KLA
 NM_010546 inhibitor of kappaB kinase beta (Ikbkb), mRNA [NM_010546] KLA 1.88 2.10 2.14 1.83 1.73 1.31 1.19
ATP .81 .74 .55 .49 .59 1.05 .96
KLA/ATP 1.86 1.73 1.39 1.12 .89 1.17 1.24
Ikbkg
KLA  ATP  ATP+KLA
 AK042138 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630062P04 product:unclassifiable, full insert sequence. [AK042138] KLA .92 .87 .78 .78 .87 .88 .62
ATP .84 .71 .80 .50 1.15 2.33 .61
KLA/ATP .72 .69 .74 .48 1.06 1.97 .68
Ikbkg
KLA  ATP  ATP+KLA
 NM_010547 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 1, mRNA [NM_010547] KLA 1.51 1.63 1.74 1.83 1.83 1.73 1.72
ATP .80 .79 .82 .75 .66 2.58 2.37
KLA/ATP 1.43 1.42 1.17 1.04 .71 1.54 3.17
Ikbkg
KLA  ATP  ATP+KLA
 NM_178590 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 2, mRNA [NM_178590] KLA .84 .93 .86 .91 1.03 .89 .88
ATP 1.03 .98 .68 .56 .51 .93 .68
KLA/ATP .89 .81 .55 .52 .41 .67 .65
Il2
KLA  ATP  ATP+KLA
 NM_008366 interleukin 2 (Il2), mRNA [NM_008366] KLA .96 .97 .96 1.00 .97 .97 .99
ATP 1.04 1.02 1.00 1.03 .97 .98 .97
KLA/ATP 1.01 .98 .97 1.00 .97 .97 .96
Il2ra
KLA  ATP  ATP+KLA
 AF054581 interleukin 2 receptor mRNA, 3UTR, partial sequence. [AF054581] KLA 1.76 2.05 2.73 2.46 3.58 2.68 1.13
ATP .99 .99 1.00 1.09 1.13 1.14 1.03
KLA/ATP 1.93 2.11 1.32 2.27 1.87 2.13 1.37
Il2ra
KLA  ATP  ATP+KLA
 NM_008367 interleukin 2 receptor, alpha chain (Il2ra), mRNA [NM_008367] KLA 1.33 1.29 1.46 1.43 1.82 1.57 1.15
ATP 1.02 1.03 1.01 1.02 1.01 1.12 1.05
KLA/ATP 1.30 1.46 1.36 1.41 1.22 1.47 1.66
Il2rb
KLA  ATP  ATP+KLA
 NM_008368 interleukin 2 receptor, beta chain (Il2rb), mRNA [NM_008368] KLA .92 1.00 1.00 1.00 .91 .98 1.09
ATP 1.02 .98 1.00 .95 1.02 1.04 1.04
KLA/ATP 1.03 .98 1.01 .99 .94 1.13 1.00
Il2rg
KLA  ATP  ATP+KLA
 NM_013563 interleukin 2 receptor, gamma chain (Il2rg), mRNA [NM_013563] KLA 2.97 2.92 3.73 3.39 4.04 3.45 4.83
ATP 1.25 1.41 1.04 1.82 1.48 1.12 2.89
KLA/ATP 3.65 4.34 2.42 4.70 2.62 2.54 5.15
Il3
KLA  ATP  ATP+KLA
 NM_010556 interleukin 3 (Il3), mRNA [NM_010556] KLA 1.05 .94 1.01 .99 1.03 1.07 .95
ATP .95 1.03 1.03 .98 .98 .97 .96
KLA/ATP 1.02 1.03 1.02 .94 .97 1.02 1.04
Il3ra
KLA  ATP  ATP+KLA
 NM_008369 interleukin 3 receptor, alpha chain (Il3ra), mRNA [NM_008369] KLA 1.23 1.35 1.52 1.31 1.38 1.42 1.35
ATP 1.04 1.20 1.11 1.42 1.18 .94 .77
KLA/ATP 1.33 1.45 1.45 1.69 1.25 1.22 1.32
Il4
KLA  ATP  ATP+KLA
 NM_021283 interleukin 4 (Il4), mRNA [NM_021283] KLA .94 .95 .91 .94 .91 .94 1.07
ATP 1.02 1.06 1.05 1.22 1.12 1.10 1.26
KLA/ATP .92 .96 .93 1.08 .98 1.03 1.18
Il4ra
KLA  ATP  ATP+KLA
 NM_001008700 interleukin 4 receptor, alpha (Il4ra), mRNA [NM_001008700] KLA 4.65 4.81 8.69 11.26 14.81 9.10 1.64
ATP .97 .88 .64 .58 3.81 9.28 4.93
KLA/ATP 4.86 4.84 5.43 3.60 4.37 10.35 6.16
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Il6ra
KLA  ATP  ATP+KLA
 NM_010559 interleukin 6 receptor, alpha (Il6ra), mRNA [NM_010559] KLA .50 .53 .65 .86 1.36 1.72 1.00
ATP .97 1.20 1.17 1.25 .74 .67 .95
KLA/ATP .50 .60 .61 .64 .59 .76 1.14
Il7
KLA  ATP  ATP+KLA
 AK041403 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630007F02 product:interleukin 7, full insert sequence [AK041403] KLA .96 .96 .97 1.00 1.01 .97 1.08
ATP 1.05 1.00 .98 .99 .94 .98 .95
KLA/ATP 1.05 1.05 .96 .99 .94 .99 .92
Il7
KLA  ATP  ATP+KLA
 NM_008371 interleukin 7 (Il7), mRNA [NM_008371] KLA 1.29 1.38 1.32 1.39 1.24 1.40 1.26
ATP 1.01 .98 1.02 .98 1.03 1.10 1.08
KLA/ATP 1.22 1.31 1.17 1.20 1.04 1.21 1.32
Il7r
KLA  ATP  ATP+KLA
 AK041838 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630041A17 product:interleukin 7 receptor, full insert sequence. [AK041838] KLA .90 1.04 .92 .95 .90 1.05 .99
ATP .97 1.01 1.11 1.04 1.06 1.33 2.92
KLA/ATP .98 .97 .91 1.10 1.06 1.20 1.57
Il7r
KLA  ATP  ATP+KLA
 NM_008372 interleukin 7 receptor (Il7r), mRNA [NM_008372] KLA .42 .40 .37 .41 .36 .60 .73
ATP 1.02 1.01 1.23 1.13 1.72 2.94 7.90
KLA/ATP .40 .41 .53 .58 1.00 2.18 4.13
Ins1
KLA  ATP  ATP+KLA
 NM_008386 insulin I (Ins1), mRNA [NM_008386] KLA 1.00 .99 .99 1.03 1.01 .98 1.06
ATP .97 1.03 1.00 1.03 .99 1.07 1.05
KLA/ATP 1.03 .93 .98 1.04 1.07 1.03 1.01
Ins2
KLA  ATP  ATP+KLA
 NM_008387 insulin II (Ins2), mRNA [NM_008387] KLA .99 1.00 1.00 1.01 1.00 1.02 1.00
ATP 1.01 .99 1.00 1.00 .98 .99 1.01
KLA/ATP .99 1.01 1.00 .98 .99 .99 .98
Insr
KLA  ATP  ATP+KLA
 NM_010568 insulin receptor (Insr), mRNA [NM_010568] KLA .75 .81 .77 .69 .69 .69 .83
ATP 1.07 1.06 .88 .79 .73 .77 .83
KLA/ATP .80 .80 .72 .71 .64 .64 .70
Irs1
KLA  ATP  ATP+KLA
 NM_010570 insulin receptor substrate 1 (Irs1), mRNA [NM_010570] KLA .97 .96 .99 1.01 .93 .94 .94
ATP 1.00 .99 1.02 .96 .96 .94 .91
KLA/ATP .96 .96 .98 .96 .97 .98 .92
Itga1
KLA  ATP  ATP+KLA
 NM_001033228 integrin alpha 1 (Itga1), mRNA [NM_001033228] KLA 1.08 1.09 1.13 1.05 1.04 .99 1.01
ATP 1.02 .97 1.03 1.03 1.09 1.43 3.50
KLA/ATP 1.06 1.04 1.07 1.00 1.06 1.12 1.33
Itga10
KLA  ATP  ATP+KLA
 NM_001081053 integrin, alpha 10 (Itga10), mRNA [NM_001081053] KLA .98 1.00 1.00 1.04 1.04 .96 1.00
ATP 1.05 1.00 .97 .98 .95 .96 .97
KLA/ATP 1.04 .98 .92 .96 .95 .97 1.00
Itga11
KLA  ATP  ATP+KLA
 NM_176922 integrin, alpha 11 (Itga11), mRNA [NM_176922] KLA .95 .92 .90 .97 .93 .93 .96
ATP .97 .92 .98 .95 .90 .94 .95
KLA/ATP .86 .94 1.01 .93 .97 .94 .88
Itga2
KLA  ATP  ATP+KLA
 NM_008396 integrin alpha 2 (Itga2), mRNA [NM_008396] KLA 1.03 1.00 .98 1.01 .97 .96 1.00
ATP 1.05 .99 .93 1.02 1.04 1.03 .97
KLA/ATP .98 1.06 1.03 1.00 1.00 1.01 1.01
Itga2b
KLA  ATP  ATP+KLA
 NM_010575 integrin alpha 2b (Itga2b), mRNA [NM_010575] KLA 1.01 1.00 .98 1.04 1.01 1.04 1.18
ATP 1.01 .98 .95 1.02 .96 1.13 1.08
KLA/ATP 1.04 1.02 1.02 .95 1.05 1.53 1.23
Itga3
KLA  ATP  ATP+KLA
 NM_013565 integrin alpha 3 (Itga3), mRNA [NM_013565] KLA 1.06 1.09 1.10 1.17 1.19 1.29 1.41
ATP .99 .99 1.05 1.12 1.20 1.25 1.33
KLA/ATP 1.08 1.14 1.15 1.27 1.28 1.20 1.39
Itga4
KLA  ATP  ATP+KLA
 NM_010576 integrin alpha 4 (Itga4), mRNA [NM_010576] KLA 4.65 4.83 4.47 3.76 2.93 1.65 1.01
ATP 1.10 1.12 1.17 1.08 .86 .75 .36
KLA/ATP 4.82 5.02 4.43 3.69 2.11 1.13 .79
Itga5
KLA  ATP  ATP+KLA
 NM_010577 integrin alpha 5 (fibronectin receptor alpha) (Itga5), mRNA [NM_010577] KLA 2.63 3.04 2.81 2.47 4.61 5.45 4.90
ATP 1.13 1.62 .74 2.21 1.31 1.93 2.84
KLA/ATP 3.55 3.84 1.15 3.03 1.11 2.81 10.42
Itga6
KLA  ATP  ATP+KLA
 BC024571 integrin alpha 6, mRNA (cDNA clone IMAGE:5036677). [BC024571] KLA .44 .44 .37 .28 .25 .29 .34
ATP .96 1.01 .90 .58 .35 .11 .22
KLA/ATP .44 .41 .34 .23 .15 .09 .08
Itga6
KLA  ATP  ATP+KLA
 NM_008397 integrin alpha 6 (Itga6), mRNA [NM_008397] KLA .57 .58 .51 .45 .43 .44 .47
ATP 1.05 1.12 .86 .90 .57 .27 .36
KLA/ATP .64 .67 .50 .57 .39 .29 .26
Itga7
KLA  ATP  ATP+KLA
 L23423 gb|Mouse (BALB/c) alpha-7 integrin mRNA, complete cds. [L23423] KLA .96 1.03 1.00 1.07 1.02 1.07 1.14
ATP 1.00 1.00 1.04 1.88 2.09 1.34 1.16
KLA/ATP 1.04 .97 1.07 1.79 1.68 1.39 1.11
Itga7
KLA  ATP  ATP+KLA
 NM_008398 integrin alpha 7 (Itga7), mRNA [NM_008398] KLA .98 .95 .98 1.01 1.04 1.03 .98
ATP 1.00 1.02 1.06 1.75 1.92 1.20 1.02
KLA/ATP 1.03 1.07 1.06 1.48 1.58 1.23 1.05
Itga8
KLA  ATP  ATP+KLA
 NM_001001309 integrin alpha 8 (Itga8), mRNA [NM_001001309] KLA .80 .81 .79 .75 .63 .61 .44
ATP .98 1.04 1.06 .94 .79 .61 .50
KLA/ATP .79 .81 .81 .71 .70 .65 .48
Itgav
KLA  ATP  ATP+KLA
 AK052514 13 days embryo lung cDNA, RIKEN full-length enriched library, clone:D430040G12 product:hypothetical protein, full insert sequence. [AK052514] KLA 1.04 .93 1.05 1.02 1.01 .93 1.03
ATP 1.05 1.04 1.13 1.12 1.12 .91 1.02
KLA/ATP 1.08 .97 1.02 .95 1.01 .96 1.05
Itgav
KLA  ATP  ATP+KLA
 AK171739 activated spleen cDNA, RIKEN full-length enriched library, clone:F830008B15 product:unclassifiable, full insert sequence. [AK171739] KLA 1.04 .97 1.06 .95 1.15 .89 1.11
ATP 1.41 1.54 1.64 2.24 2.74 1.24 1.18
KLA/ATP 1.09 1.07 1.03 1.01 1.72 1.24 1.10
Itgav
KLA  ATP  ATP+KLA
 NM_008402 integrin alpha V (Itgav), mRNA [NM_008402] KLA 4.00 3.99 3.28 2.24 1.57 .95 1.13
ATP 1.14 1.22 1.13 1.39 2.22 2.47 1.70
KLA/ATP 4.59 4.61 2.48 2.44 1.60 1.88 2.56
Itgb1
KLA  ATP  ATP+KLA
 NM_010578 integrin beta 1 (fibronectin receptor beta) (Itgb1), mRNA [NM_010578] KLA 1.05 1.09 1.13 .92 1.01 .93 .88
ATP 1.14 1.30 .92 1.07 1.04 .83 .70
KLA/ATP 1.26 1.30 .87 1.02 .66 .65 .62
Itgb1
KLA  ATP  ATP+KLA
 U37029 integrin beta1D mRNA, partial cds. [U37029] KLA .93 .95 .96 1.01 .97 1.01 .98
ATP 1.05 .99 .99 1.03 1.03 .97 .94
KLA/ATP .99 .98 1.04 .97 1.02 1.01 .99
Itgb3
KLA  ATP  ATP+KLA
 AF026509 integrin beta3 subunit mRNA, complete cds. [AF026509] KLA 2.38 2.64 2.65 3.15 4.02 4.46 2.83
ATP 1.21 1.17 1.25 1.62 2.33 3.09 4.78
KLA/ATP 2.48 2.63 3.39 3.72 4.30 4.71 6.79
Itgb3
KLA  ATP  ATP+KLA
 NM_016780 integrin beta 3 (Itgb3), mRNA [NM_016780] KLA .50 .51 .52 .41 .31 .25 .15
ATP .94 .88 1.17 .89 .99 1.36 .91
KLA/ATP .51 .54 .67 .52 .61 .74 .48
Itgb4
KLA  ATP  ATP+KLA
 AK048888 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230078O20 product:integrin beta 4, full insert sequence. [AK048888] KLA .98 .92 .98 1.08 .97 1.02 1.02
ATP .99 .99 .91 1.03 1.02 1.00 1.05
KLA/ATP .99 1.03 .99 .98 .94 .98 1.01
Itgb4
KLA  ATP  ATP+KLA
 NM_001005608 integrin beta 4 (Itgb4), transcript variant 1, mRNA [NM_001005608] KLA 1.09 1.11 1.12 1.08 .98 .86 .85
ATP .90 .89 .90 .95 .87 .87 .84
KLA/ATP 1.06 1.08 1.10 1.18 1.07 .90 .76
Itgb5
KLA  ATP  ATP+KLA
 NM_010580 integrin beta 5 (Itgb5), mRNA [NM_010580] KLA .72 .68 .67 .66 .54 .43 .36
ATP 1.09 .94 .78 .57 .63 .56 .62
KLA/ATP .78 .64 .67 .51 .64 .67 .38
Itgb6
KLA  ATP  ATP+KLA
 NM_021359 integrin beta 6 (Itgb6), mRNA [NM_021359] KLA .97 1.02 1.04 1.06 1.06 1.04 1.01
ATP .99 1.00 1.01 .96 1.04 1.00 1.00
KLA/ATP .99 1.03 1.08 1.02 1.02 1.03 1.01
Itgb7
KLA  ATP  ATP+KLA
 NM_013566 integrin beta 7 (Itgb7), mRNA [NM_013566] KLA .91 .88 .93 1.19 .93 .76 .79
ATP 1.00 .96 1.30 1.44 2.84 3.07 7.90
KLA/ATP .96 1.05 1.35 1.20 2.70 3.53 8.17
Itgb8
KLA  ATP  ATP+KLA
 AK029281 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832412O06 product:SIMILAR TO INTEGRIN, BETA 8 homolog [Homo sapiens], full insert sequence. [AK029281] KLA 4.66 5.00 3.59 2.70 1.76 1.34 1.32
ATP 1.01 .98 1.09 1.16 2.15 5.24 1.17
KLA/ATP 5.59 6.39 4.38 1.99 1.84 2.55 2.11
Itgb8
KLA  ATP  ATP+KLA
 AK034644 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430018C17 product:integrin beta 8, full insert sequence. [AK034644] KLA 1.18 1.02 1.04 1.03 1.05 .94 .93
ATP .96 .97 .97 .96 .90 1.04 .99
KLA/ATP 1.06 1.06 1.15 .92 .99 1.00 1.09
Itgb8
KLA  ATP  ATP+KLA
 AK140969 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130086L01 product:hypothetical protein, full insert sequence [AK140969] KLA 3.63 3.76 4.16 3.31 2.72 1.58 1.40
ATP .98 1.01 1.31 1.14 1.28 6.11 1.65
KLA/ATP 3.84 4.18 3.75 2.83 1.92 3.44 4.81
Jak1
KLA  ATP  ATP+KLA
 AK029232 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831433J01 product:Janus kinase 1, full insert sequence. [AK029232] KLA 1.25 1.13 1.19 1.31 1.24 1.17 1.14
ATP 1.01 1.11 .96 1.38 1.06 1.26 1.05
KLA/ATP 1.19 1.29 1.27 1.59 1.18 1.38 1.24
Jak1
KLA  ATP  ATP+KLA
 NM_146145 Janus kinase 1 (Jak1), mRNA [NM_146145] KLA 1.71 1.75 1.79 1.81 1.72 1.37 1.21
ATP 1.03 1.01 .75 1.04 1.32 1.90 1.14
KLA/ATP 1.84 1.73 1.49 2.07 2.01 1.83 1.68
Jak2
KLA  ATP  ATP+KLA
 NM_008413 Janus kinase 2 (Jak2), transcript variant 1, mRNA [NM_008413] KLA 14.86 15.05 15.42 14.15 11.46 8.81 5.47
ATP .99 1.06 1.09 1.43 2.83 4.71 1.62
KLA/ATP 13.77 14.74 14.94 12.97 7.53 9.34 9.17
Jak3
KLA  ATP  ATP+KLA
 NM_010589 Janus kinase 3 (Jak3), mRNA [NM_010589] KLA 1.46 1.56 1.79 1.62 2.05 1.72 1.65
ATP 1.11 1.19 .84 1.25 .82 .61 .71
KLA/ATP 1.76 1.82 1.10 1.74 .93 .83 1.01
Kdr
KLA  ATP  ATP+KLA
 AK054510 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330034B14 product:kinase insert domain protein receptor, full insert sequence. [AK054510] KLA 1.00 1.00 .98 1.03 1.02 1.00 .99
ATP .99 1.00 1.00 1.02 1.00 1.00 1.00
KLA/ATP 1.01 1.02 1.03 1.02 .98 1.00 1.01
Kdr
KLA  ATP  ATP+KLA
 NM_010612 kinase insert domain protein receptor (Kdr), mRNA [NM_010612] KLA 7.30 7.28 6.48 6.79 5.97 6.18 2.71
ATP 1.00 .84 1.06 1.14 3.62 3.10 7.15
KLA/ATP 6.62 7.17 7.12 6.48 14.11 12.63 11.01
Kit
KLA  ATP  ATP+KLA
 Y00864 gb|Mouse c-kit mRNA. [Y00864] KLA .88 .86 .83 .76 .75 .73 .87
ATP 1.06 1.07 1.03 1.04 3.95 1.93 1.25
KLA/ATP .87 .87 .89 .89 1.06 1.08 .91
Kitl
KLA  ATP  ATP+KLA
 NM_013598 kit ligand (Kitl), mRNA [NM_013598] KLA .49 .46 .43 .38 .23 .35 .46
ATP .89 .85 .79 .91 1.14 1.30 .86
KLA/ATP .48 .43 .49 .96 1.59 1.38 .95
Klk1b4
KLA  ATP  ATP+KLA
 NM_010915 kallikrein 1-related pepidase b4 (Klk1b4), mRNA [NM_010915] KLA 1.07 1.10 1.07 1.02 1.06 .95 1.04
ATP .94 1.05 1.03 .97 .94 1.07 1.10
KLA/ATP .96 .97 1.13 1.09 .99 .99 .99
Kras
KLA  ATP  ATP+KLA
 NM_021284 v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (Kras), mRNA [NM_021284] KLA .53 .49 .40 .42 .49 .95 1.05
ATP .98 1.01 1.16 1.17 1.39 1.29 1.74
KLA/ATP .50 .47 .50 .56 1.00 1.24 1.58
Lama1
KLA  ATP  ATP+KLA
 NM_008480 laminin, alpha 1 (Lama1), mRNA [NM_008480] KLA .99 1.04 .97 .96 1.01 .99 1.05
ATP 1.01 .99 .98 1.05 .99 1.09 .99
KLA/ATP 1.00 .97 .86 1.04 1.05 .99 1.00
Lama2
KLA  ATP  ATP+KLA
 AK046114 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230342M05 product:laminin, alpha 2, full insert sequence. [AK046114] KLA 1.06 1.00 .95 1.10 1.04 .99 .96
ATP .98 1.09 1.00 .97 .96 1.12 1.01
KLA/ATP .94 1.04 1.05 1.00 .99 1.00 .98
Lama2
KLA  ATP  ATP+KLA
 NM_008481 laminin, alpha 2 (Lama2), mRNA [NM_008481] KLA .96 .99 .96 1.02 .95 1.00 .97
ATP 1.05 1.00 1.01 .94 1.01 1.04 .96
KLA/ATP .99 1.04 1.06 1.10 .98 .95 .97
Lama2
KLA  ATP  ATP+KLA
 U12147 laminin-2 alpha2 chain mRNA, complete cds. [U12147] KLA .96 1.00 .99 1.00 .98 1.02 1.03
ATP 1.01 .99 1.02 1.04 1.01 .99 1.02
KLA/ATP 1.00 1.01 1.00 1.01 .99 1.04 1.00
Lama3
KLA  ATP  ATP+KLA
 XM_140451 gb|PREDICTED: Mus musculus laminin, alpha 3, transcript variant 1 (Lama3), mRNA [XM_140451] KLA .76 .75 .73 .75 .71 .74 .67
ATP 1.04 1.12 1.05 1.20 .88 .73 .78
KLA/ATP .77 .81 .78 .82 .78 .71 .70
Lama4
KLA  ATP  ATP+KLA
 NM_010681 laminin, alpha 4 (Lama4), mRNA [NM_010681] KLA .99 .99 1.01 1.02 .98 .97 .96
ATP 1.00 1.08 1.05 1.05 1.03 1.04 .96
KLA/ATP 1.00 1.03 .93 1.00 .94 .90 .95
Lama5
KLA  ATP  ATP+KLA
 NM_001081171 laminin, alpha 5 (Lama5), mRNA [NM_001081171] KLA 1.11 1.07 1.09 1.00 .96 1.00 1.01
ATP 1.01 .99 1.03 1.01 1.00 .99 .99
KLA/ATP 1.12 1.08 1.05 1.04 .99 1.09 1.04
Lamb1-1
KLA  ATP  ATP+KLA
 NM_008482 laminin B1 subunit 1 (Lamb1-1), mRNA [NM_008482] KLA .93 .99 1.10 1.01 .95 1.00 .86
ATP .99 1.13 1.06 .99 1.07 .99 .97
KLA/ATP 1.00 1.06 .98 .95 .93 .89 1.04
Lamb2
KLA  ATP  ATP+KLA
 NM_008483 laminin, beta 2 (Lamb2), mRNA [NM_008483] KLA .93 .90 .95 .81 .79 .58 .37
ATP 1.01 1.09 .95 .99 .80 .81 .38
KLA/ATP .96 .87 1.00 .91 .72 .60 .38
Lamb3
KLA  ATP  ATP+KLA
 NM_008484 laminin, beta 3 (Lamb3), mRNA [NM_008484] KLA 1.00 .97 1.02 .98 1.00 1.04 .93
ATP 1.01 1.01 .91 .97 .89 1.04 1.03
KLA/ATP 1.00 .95 .97 1.00 .95 .87 1.02
Lamc1
KLA  ATP  ATP+KLA
 J03484 gb|Mouse laminin B2 chain mRNA, complete cds [J03484] KLA 1.14 1.01 1.04 .87 .82 .63 .75
ATP .99 1.09 1.07 1.14 1.36 2.38 .66
KLA/ATP 1.04 1.10 .95 1.12 1.30 1.70 .68
Lamc2
KLA  ATP  ATP+KLA
 AF106279 laminin gamma2 chain mRNA, partial cds. [AF106279] KLA 1.03 1.04 1.03 1.09 .97 .97 .98
ATP 1.04 1.04 1.16 1.48 1.46 1.29 1.26
KLA/ATP 1.04 1.00 1.03 1.06 .95 .99 1.08
Lamc2
KLA  ATP  ATP+KLA
 NM_008485 laminin, gamma 2 (Lamc2), mRNA [NM_008485] KLA 1.16 1.22 1.23 1.07 1.04 1.12 1.04
ATP 1.01 1.10 2.81 4.58 4.35 3.34 2.36
KLA/ATP 1.31 1.29 1.41 1.40 1.28 1.25 1.49
Lamc3
KLA  ATP  ATP+KLA
 AF083372 laminin 12 gamma 3 chain mRNA, complete cds. [AF083372] KLA .96 .94 .99 .96 .94 1.02 .88
ATP 1.06 1.00 .95 .98 .98 .99 1.02
KLA/ATP .90 .98 1.03 .95 .88 .97 .96
Lamc3
KLA  ATP  ATP+KLA
 NM_011836 laminin gamma 3 (Lamc3), mRNA [NM_011836] KLA 1.00 1.00 1.04 1.04 1.03 1.01 .97
ATP .99 1.06 1.00 .91 .98 .96 1.01
KLA/ATP .98 1.04 1.01 1.02 .96 .95 .98
Lpar2
KLA  ATP  ATP+KLA
 NM_020028 lysophosphatidic acid receptor 2 (Lpar2), mRNA [NM_020028] KLA .80 .84 .81 .80 .72 .71 .78
ATP 1.08 1.02 1.00 1.14 1.02 .82 .75
KLA/ATP .98 .82 .87 .81 1.06 .76 .69
Lpar3
KLA  ATP  ATP+KLA
 NM_022983 lysophosphatidic acid receptor 3 (Lpar3), mRNA [NM_022983] KLA 1.04 1.04 1.09 1.01 .96 .96 .97
ATP .98 .97 .94 1.07 1.06 1.04 .98
KLA/ATP 1.05 1.14 1.02 1.06 1.24 1.06 1.01
Lpar4
KLA  ATP  ATP+KLA
 NM_175271 lysophosphatidic acid receptor 4 (Lpar4), mRNA [NM_175271] KLA 1.15 1.14 1.12 1.07 .98 1.00 1.04
ATP 1.06 1.00 1.07 .98 .94 .99 .94
KLA/ATP 1.15 1.17 1.14 1.13 1.05 1.08 1.01
Lpar5
KLA  ATP  ATP+KLA
 XM_355812 gb|PREDICTED: Mus musculus G protein-coupled receptor 92 (Gpr92), mRNA [XM_355812] KLA 1.15 1.19 1.13 1.20 1.00 1.13 1.05
ATP .99 1.06 1.08 1.03 .84 1.00 .99
KLA/ATP 1.11 1.24 1.26 1.17 1.16 .98 .98
Map2k1
KLA  ATP  ATP+KLA
 NM_008927 mitogen-activated protein kinase kinase 1 (Map2k1), mRNA [NM_008927] KLA 1.82 2.00 2.31 2.03 2.51 2.20 1.51
ATP .99 1.14 .81 .87 .90 1.57 1.11
KLA/ATP 1.90 2.03 1.50 1.93 1.63 2.03 2.06
Map2k2
KLA  ATP  ATP+KLA
 NM_023138 mitogen-activated protein kinase kinase 2 (Map2k2), mRNA [NM_023138] KLA .96 1.01 1.09 .99 1.11 1.15 1.42
ATP 1.07 1.05 .74 .86 1.04 1.16 1.21
KLA/ATP 1.14 1.03 .68 .78 .85 1.01 1.20
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mcl1
KLA  ATP  ATP+KLA
 NM_008562 myeloid cell leukemia sequence 1 (Mcl1), mRNA [NM_008562] KLA 1.08 1.07 1.20 1.31 1.66 1.91 2.02
ATP 1.13 1.19 .82 .84 1.60 1.74 2.17
KLA/ATP 1.09 1.18 .81 .90 1.75 2.48 3.72
Mdm2
KLA  ATP  ATP+KLA
 NM_010786 transformed mouse 3T3 cell double minute 2 (Mdm2), mRNA [NM_010786] KLA 1.77 1.59 1.98 1.51 1.77 1.60 1.77
ATP 1.01 1.21 1.36 3.24 5.04 2.08 1.36
KLA/ATP 1.89 1.86 2.93 5.65 5.98 2.78 2.64
Met
KLA  ATP  ATP+KLA
 NM_008591 met proto-oncogene (Met), mRNA [NM_008591] KLA 3.56 3.71 3.68 3.79 4.24 5.89 6.95
ATP .98 .96 1.16 1.21 3.32 12.98 6.60
KLA/ATP 3.75 3.80 3.58 3.28 3.69 4.27 14.22
Mm.19309
9
KLA  ATP  ATP+KLA
 46849811 Unknown KLA 1.32 1.36 1.42 1.17 1.06 .90 .58
ATP .98 1.12 1.41 1.81 1.44 1.14 .89
KLA/ATP 1.39 1.55 1.57 2.02 1.43 1.12 .74
Mm.21312
8
KLA  ATP  ATP+KLA
 141801344 Unknown KLA .96 .95 .83 .77 .52 .99 1.32
ATP .80 .82 1.09 .80 .83 1.19 1.46
KLA/ATP .78 .92 .98 .62 .71 .94 1.41
Mm.24060
7
KLA  ATP  ATP+KLA
 162951825 Unknown KLA .94 .96 .91 1.02 .90 .84 .97
ATP 1.08 1.01 1.08 .95 1.04 .89 .89
KLA/ATP .93 1.01 1.05 .92 .84 .88 .76
Mm.25381
9
KLA  ATP  ATP+KLA
 118130676 Unknown KLA 1.81 1.88 1.96 1.62 1.89 2.44 1.56
ATP .92 .91 1.24 1.01 1.16 2.06 1.95
KLA/ATP 1.62 1.86 1.86 1.41 1.89 2.37 1.97
Mm.25806
5
KLA  ATP  ATP+KLA
 148747407 Unknown KLA 1.05 1.02 1.03 1.00 .99 1.05 .94
ATP .98 .98 1.03 1.02 .99 1.06 1.03
KLA/ATP 1.01 1.02 1.03 1.01 .96 .98 1.01
Mm.27304
9
KLA  ATP  ATP+KLA
 119672895 Unknown KLA .23 .22 .22 .22 .30 .51 .16
ATP 1.08 1.05 .88 .78 .47 .09 .20
KLA/ATP .28 .22 .21 .24 .26 .22 .12
Mm.27574
2
KLA  ATP  ATP+KLA
 112983655 Unknown KLA 1.35 1.16 .94 .85 .45 .33 .31
ATP .90 .86 1.17 1.09 1.18 1.21 .38
KLA/ATP 1.12 1.22 1.19 .91 .90 .83 .33
Mm.29002
2
KLA  ATP  ATP+KLA
 167234371 Unknown KLA .53 .50 .44 .38 .36 .39 .57
ATP 1.01 1.07 1.01 1.02 .84 .42 .40
KLA/ATP .53 .51 .38 .41 .47 .40 .21
Mm.33981
2
KLA  ATP  ATP+KLA
 6679780 Unknown KLA 1.10 1.14 1.09 1.05 1.05 1.08 1.01
ATP .95 1.06 2.35 11.15 2.46 1.50 1.03
KLA/ATP 1.02 1.05 2.05 8.78 2.65 1.76 1.02
Mm.37708
7
KLA  ATP  ATP+KLA
 158631169 Unknown KLA .98 .98 1.06 1.06 .91 .97 1.04
ATP 1.00 1.07 1.01 1.06 1.09 .99 1.02
KLA/ATP 1.08 1.06 1.16 1.11 1.16 1.12 1.04
Mm.38049
KLA  ATP  ATP+KLA
 118130391 Unknown KLA .67 .65 .73 .92 .63 .81 .76
ATP .93 .92 1.08 .54 .45 1.48 1.56
KLA/ATP .57 .65 .98 .67 .44 .78 1.16
Mm.42523
6
KLA  ATP  ATP+KLA
 117320553 Unknown KLA .98 .98 1.03 1.00 .99 1.02 1.02
ATP 1.01 .99 1.03 1.02 1.05 .94 .96
KLA/ATP 1.08 1.04 1.06 1.01 1.00 1.01 1.05
Mm.42730
7
KLA  ATP  ATP+KLA
 109809755 Unknown KLA 1.07 1.13 .97 1.03 1.01 .96 1.09
ATP 1.01 1.02 .92 .94 .72 .73 .87
KLA/ATP 1.08 1.13 .93 .89 .85 .79 .70
Mm.4387
KLA  ATP  ATP+KLA
 133892666 Unknown KLA .85 .87 .85 .89 .77 .91 1.18
ATP 1.01 1.01 .87 1.07 .75 .86 .93
KLA/ATP .88 .86 .77 .81 .72 .91 .84
Mm.44050
5
KLA  ATP  ATP+KLA
 84579905 Unknown KLA 1.03 .96 .90 1.03 .94 1.15 1.23
ATP .88 .91 1.15 1.18 1.17 1.31 1.02
KLA/ATP .87 .97 1.19 1.18 1.36 1.34 1.25
Mm.46042
5
KLA  ATP  ATP+KLA
 145699103 Unknown KLA .97 1.06 1.00 1.00 1.04 1.00 1.06
ATP .98 1.03 .96 .96 1.00 1.05 .96
KLA/ATP .99 .95 1.04 .97 1.01 .98 .93
Mm.47351
0
KLA  ATP  ATP+KLA
 162287332 Unknown KLA 4.46 4.82 5.29 4.00 2.26 1.25 1.10
ATP 1.24 1.72 1.02 2.08 1.66 2.53 .55
KLA/ATP 6.11 7.67 4.29 6.99 3.11 2.86 2.30
Mm.47445
5
KLA  ATP  ATP+KLA
 149260531 Unknown KLA .99 .93 .95 .92 .97 .92 .95
ATP .99 1.13 1.08 1.23 1.05 .94 .86
KLA/ATP 1.02 .95 .89 1.15 1.02 .94 .83
Mm.4987
KLA  ATP  ATP+KLA
 160358832 Unknown KLA 1.04 1.02 1.05 1.00 1.06 1.02 1.00
ATP 1.11 1.00 1.08 1.01 1.05 1.09 1.04
KLA/ATP 1.08 1.05 .94 1.04 1.06 1.11 .99
Mm.5055
KLA  ATP  ATP+KLA
 145966820 Unknown KLA 1.04 .96 1.04 .97 1.00 1.00 .97
ATP .95 .97 .96 .95 .97 .97 .98
KLA/ATP .88 1.04 1.07 1.02 .97 .98 .96
Mm.57127
KLA  ATP  ATP+KLA
 117168292 Unknown KLA 1.20 1.25 1.28 1.18 1.14 1.13 1.12
ATP .98 .95 1.11 1.06 1.05 1.05 1.09
KLA/ATP 1.22 1.24 1.48 1.55 1.40 1.21 1.07
Mtcp1
KLA  ATP  ATP+KLA
 NM_001039373 mature T-cell proliferation 1 (Mtcp1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_001039373] KLA 1.14 1.17 1.35 1.31 1.25 1.32 1.29
ATP .96 1.04 .97 .93 .78 .81 .93
KLA/ATP 1.22 1.17 1.21 1.18 1.12 1.11 1.11
Mtcp1
KLA  ATP  ATP+KLA
 NM_010839 mature T-cell proliferation 1 (Mtcp1), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_010839] KLA 1.31 1.30 1.48 1.43 1.35 1.51 1.36
ATP .84 .80 .95 1.00 .89 .82 .68
KLA/ATP 1.06 .97 1.07 1.31 1.70 1.46 1.49
Myb
KLA  ATP  ATP+KLA
 AK036518 adult male bone cDNA, RIKEN full-length enriched library, clone:9830125P17 product:myeloblastosis oncogene, full insert sequence. [AK036518] KLA 1.02 .96 1.03 1.00 .96 1.07 .99
ATP 1.07 .96 1.03 .99 .96 1.03 1.00
KLA/ATP 1.04 1.07 .83 .93 1.06 1.03 1.00
Myb
KLA  ATP  ATP+KLA
 M16449 gb|Mouse myb mRNA, complete cds [M16449] KLA .97 1.07 1.09 1.01 1.01 1.02 .98
ATP 1.06 .98 1.05 1.06 .91 .91 .84
KLA/ATP 1.08 1.07 .80 1.03 1.01 .92 .90
Myb
KLA  ATP  ATP+KLA
 NM_010848 myeloblastosis oncogene (Myb), mRNA [NM_010848] KLA 1.07 1.05 1.11 1.09 1.06 .99 .91
ATP .99 1.05 1.05 .95 .94 .93 .82
KLA/ATP 1.04 1.09 1.07 .97 .94 .95 .82
Myc
KLA  ATP  ATP+KLA
 NM_010849 myelocytomatosis oncogene (Myc), mRNA [NM_010849] KLA .38 .31 .45 .45 .49 .35 .33
ATP 1.05 1.09 1.72 4.41 1.28 .45 .76
KLA/ATP .37 .30 .44 1.23 .34 .17 .19
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Ngf
KLA  ATP  ATP+KLA
 NM_013609 nerve growth factor (Ngf), transcript variant A, mRNA [NM_013609] KLA .99 .98 .97 .99 .97 1.10 1.05
ATP .94 1.03 .99 1.00 .93 1.05 1.01
KLA/ATP .94 1.01 .99 .98 .98 1.11 1.02
Ngfr
KLA  ATP  ATP+KLA
 NM_033217 nerve growth factor receptor (TNFR superfamily, member 16) (Ngfr), mRNA [NM_033217] KLA 1.06 1.08 1.08 1.06 1.07 1.09 1.08
ATP .99 1.01 1.06 1.03 1.01 1.04 1.04
KLA/ATP 1.04 1.07 1.08 1.06 1.05 1.04 1.11
Nos3
KLA  ATP  ATP+KLA
 NM_008713 nitric oxide synthase 3, endothelial cell (Nos3), mRNA [NM_008713] KLA .83 .79 .76 .78 .77 .85 .96
ATP 1.03 1.09 1.03 1.02 .85 .96 1.84
KLA/ATP .80 .78 .79 .80 .79 .78 .91
Nr4a1
KLA  ATP  ATP+KLA
 NM_010444 nuclear receptor subfamily 4, group A, member 1 (Nr4a1), mRNA [NM_010444] KLA .44 .45 .47 .82 .71 .50 .55
ATP 11.54 20.34 46.57 49.45 32.16 7.11 .84
KLA/ATP 4.55 17.35 51.68 56.03 42.95 13.43 2.21
Nras
KLA  ATP  ATP+KLA
 NM_010937 neuroblastoma ras oncogene (Nras), mRNA [NM_010937] KLA 1.20 1.22 1.27 1.20 1.09 .91 .84
ATP .98 .91 .69 .61 .59 .67 .78
KLA/ATP 1.22 1.14 .97 .79 .73 .61 .72
Osm
KLA  ATP  ATP+KLA
 NM_001013365 oncostatin M (Osm), mRNA [NM_001013365] KLA 1.56 1.46 1.46 2.02 1.99 1.68 1.47
ATP 2.40 4.29 10.76 14.66 10.66 9.53 2.21
KLA/ATP 1.94 3.15 10.63 13.85 12.20 11.12 5.30
Osmr
KLA  ATP  ATP+KLA
 NM_011019 oncostatin M receptor (Osmr), mRNA [NM_011019] KLA 1.18 1.26 1.23 1.16 1.13 1.08 1.03
ATP 1.02 1.00 1.04 1.04 1.10 1.07 1.04
KLA/ATP 1.21 1.17 1.17 1.14 1.19 1.10 1.08
P2ry5
KLA  ATP  ATP+KLA
 NM_175116 purinergic receptor P2Y, G-protein coupled, 5 (P2ry5), mRNA [NM_175116] KLA .16 .17 .21 .19 .20 .33 .28
ATP 1.25 1.44 1.75 1.01 .54 1.08 .90
KLA/ATP .17 .17 .26 .27 .35 .49 .57
Pck2
KLA  ATP  ATP+KLA
 NM_028994 phosphoenolpyruvate carboxykinase 2 (mitochondrial) (Pck2), nuclear gene encoding mitochondrial protein, mRNA [NM_028994] KLA .40 .37 .32 .28 .37 .56 .55
ATP .99 .96 .86 .94 1.02 .57 .77
KLA/ATP .40 .37 .31 .35 .42 .35 .46
Pdgfa
KLA  ATP  ATP+KLA
 NM_008808 platelet derived growth factor, alpha (Pdgfa), mRNA [NM_008808] KLA .63 .56 .42 .34 .31 .33 .52
ATP .89 .80 .69 1.23 5.97 3.99 2.73
KLA/ATP .64 .53 .43 .77 3.48 3.78 2.37
Pdgfb
KLA  ATP  ATP+KLA
 NM_011057 platelet derived growth factor, B polypeptide (Pdgfb), mRNA [NM_011057] KLA .45 .43 .38 .46 .69 .48 .58
ATP .94 .95 .66 .74 .67 .77 1.06
KLA/ATP .43 .43 .37 .39 .52 .55 1.64
Pdgfc
KLA  ATP  ATP+KLA
 AK081347 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130008P20 product:platelet-derived growth factor, C polypeptide, full insert sequence. [AK081347] KLA .93 1.07 1.00 1.03 .93 .95 .98
ATP 1.05 1.04 .94 1.02 1.04 1.00 1.05
KLA/ATP 1.06 1.02 .99 .96 .99 1.05 1.01
Pdgfc
KLA  ATP  ATP+KLA
 NM_019971 platelet-derived growth factor, C polypeptide (Pdgfc), mRNA [NM_019971] KLA 1.56 1.52 1.84 2.08 1.83 1.33 .79
ATP .98 .91 .86 .91 .78 1.43 3.28
KLA/ATP 1.45 1.50 1.25 1.73 1.99 1.56 1.12
Pdgfd
KLA  ATP  ATP+KLA
 AK141551 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630020I23 product:platelet-derived growth factor, D polypeptide, full insert sequence [AK141551] KLA 1.07 1.01 1.06 .98 .94 1.00 1.00
ATP .98 .99 1.10 1.00 .96 1.00 .94
KLA/ATP 1.00 1.03 1.05 1.02 .94 .97 1.03
Pdgfd
KLA  ATP  ATP+KLA
 NM_027924 platelet-derived growth factor, D polypeptide (Pdgfd), mRNA [NM_027924] KLA .99 .93 .95 .97 1.00 .99 .95
ATP 1.01 .99 1.00 .93 1.05 1.04 1.06
KLA/ATP .91 .91 .96 .92 .92 .99 1.05
Pdgfra
KLA  ATP  ATP+KLA
 NM_011058 platelet derived growth factor receptor, alpha polypeptide (Pdgfra), transcript variant 1, mRNA [NM_011058] KLA 1.02 1.05 1.02 1.01 1.03 1.03 1.01
ATP 1.01 1.02 1.03 1.04 1.00 1.01 1.01
KLA/ATP 1.01 1.01 .99 1.03 1.02 1.03 1.01
Pdgfrb
KLA  ATP  ATP+KLA
 NM_008809 platelet derived growth factor receptor, beta polypeptide (Pdgfrb), mRNA [NM_008809] KLA 4.85 5.49 4.56 3.94 3.71 2.05 1.51
ATP .99 1.00 1.11 1.27 1.02 1.83 1.23
KLA/ATP 5.09 5.86 4.30 2.51 1.74 1.84 3.23
Pdpk1
KLA  ATP  ATP+KLA
 NM_011062 3-phosphoinositide dependent protein kinase-1 (Pdpk1), transcript variant 1, mRNA [NM_011062] KLA .90 .90 .84 1.00 1.32 1.19 1.15
ATP 1.05 1.09 1.04 1.14 1.31 .97 1.17
KLA/ATP .90 .89 .91 1.02 1.27 .96 1.42
Pgf
KLA  ATP  ATP+KLA
 NM_008827 placental growth factor (Pgf), mRNA [NM_008827] KLA 1.59 1.43 1.58 1.66 1.51 1.67 1.19
ATP .94 1.05 1.49 3.36 5.65 4.56 3.89
KLA/ATP 1.64 1.61 1.95 2.17 3.19 4.33 4.95
Phlpp
KLA  ATP  ATP+KLA
 XM_129968 gb|PREDICTED: Mus musculus PH domain and leucine rich repeat protein phosphatase, transcript variant 1 (Phlpp), mRNA [XM_129968] KLA 4.22 4.69 7.54 5.41 3.09 2.10 2.09
ATP 1.09 1.23 1.03 2.83 3.71 2.88 1.35
KLA/ATP 4.68 5.42 4.74 10.16 10.52 8.94 4.30
Phlppl
KLA  ATP  ATP+KLA
 NM_001122594 PH domain and leucine rich repeat protein phosphatase-like (Phlppl), mRNA [NM_001122594] KLA 1.93 1.82 1.81 1.66 1.16 1.23 .98
ATP .98 .95 1.25 .98 1.47 1.70 .88
KLA/ATP 1.76 1.78 2.15 1.54 3.12 2.24 1.08
Pik3ap1
KLA  ATP  ATP+KLA
 AK171021 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630218N05 product:phosphoinositide-3-kinase adaptor protein 1, full insert sequence [AK171021] KLA 1.50 1.68 2.02 1.89 2.34 2.36 2.67
ATP 1.08 1.14 .70 .73 .70 .68 2.56
KLA/ATP 1.78 1.63 .94 1.38 .94 1.40 3.40
Pik3ap1
KLA  ATP  ATP+KLA
 NM_031376 phosphoinositide-3-kinase adaptor protein 1 (Pik3ap1), mRNA [NM_031376] KLA 1.95 1.92 2.40 2.59 3.05 2.56 2.75
ATP 1.18 1.21 .79 1.07 .98 1.00 2.68
KLA/ATP 2.18 2.33 1.85 2.35 1.31 1.87 4.82
Pik3ca
KLA  ATP  ATP+KLA
 ENSMUST00000108243 ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] KLA 1.07 1.01 .91 .90 .98 .96 .86
ATP 1.03 .87 1.12 .63 1.22 1.86 .60
KLA/ATP 1.05 .82 .91 .61 1.17 1.26 .63
Pik3ca
KLA  ATP  ATP+KLA
 NM_008839 phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] KLA 1.15 1.11 1.05 .82 .99 1.03 1.27
ATP .98 1.00 .79 .75 .96 1.32 1.10
KLA/ATP 1.10 .98 .64 .72 .80 1.20 1.41
Pik3cb
KLA  ATP  ATP+KLA
 NM_029094 phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] KLA 1.06 1.06 1.03 .73 .68 .98 1.69
ATP 1.04 1.21 .95 1.02 .85 .93 1.73
KLA/ATP 1.15 1.27 .73 .83 .58 .81 1.81
Pik3cd
KLA  ATP  ATP+KLA
 NM_008840 phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] KLA 2.28 2.42 3.10 4.17 3.35 2.31 1.34
ATP 1.02 .91 .99 .63 .30 .67 .80
KLA/ATP 2.14 2.23 2.70 1.51 1.17 .85 .72
Pik3cd
KLA  ATP  ATP+KLA
 U86587 phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] KLA 2.21 2.24 3.71 3.17 3.67 2.66 1.48
ATP 1.00 1.03 .93 .96 .46 .75 .97
KLA/ATP 2.27 2.32 1.97 2.02 1.01 .99 .98
Pik3cg
KLA  ATP  ATP+KLA
 NM_020272 phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] KLA .53 .53 .61 .64 .97 .86 .79
ATP 1.01 1.13 .88 .89 .52 .53 .53
KLA/ATP .58 .53 .43 .60 .40 .43 .62
Pik3r1
KLA  ATP  ATP+KLA
 NM_001077495 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] KLA 1.05 1.07 1.03 1.00 1.01 1.20 .85
ATP .97 1.02 1.48 1.42 1.76 1.33 1.23
KLA/ATP 1.11 1.12 1.06 1.17 1.24 .99 1.12
Pik3r2
KLA  ATP  ATP+KLA
 NM_008841 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] KLA .50 .50 .48 .43 .46 .66 .75
ATP .78 .68 .45 .43 .28 .57 1.37
KLA/ATP .49 .38 .32 .33 .38 .67 1.10
Pik3r3
KLA  ATP  ATP+KLA
 NM_181585 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] KLA 1.59 1.49 1.37 1.17 1.05 1.55 1.41
ATP 1.12 1.00 1.33 1.70 2.01 2.37 2.02
KLA/ATP 1.63 1.54 1.58 1.70 2.43 2.68 1.92
Pik3r5
KLA  ATP  ATP+KLA
 NM_177320 phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] KLA 3.57 3.58 4.16 3.54 4.11 2.59 2.39
ATP 1.08 1.08 .93 1.67 3.11 1.88 1.34
KLA/ATP 3.91 3.70 3.30 3.80 2.70 2.04 3.00
Pkn1
KLA  ATP  ATP+KLA
 NM_177262 protein kinase N1 (Pkn1), mRNA [NM_177262] KLA 1.00 1.05 1.21 1.17 1.81 2.23 1.45
ATP 1.04 1.08 .91 1.07 .93 1.41 2.42
KLA/ATP 1.09 1.06 .93 1.08 .91 1.73 3.64
Pkn2
KLA  ATP  ATP+KLA
 AK140746 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130001L23 product:protein kinase N2, full insert sequence [AK140746] KLA 2.11 2.12 2.30 1.86 1.65 1.52 1.45
ATP 1.03 1.09 .93 .96 1.69 1.26 1.10
KLA/ATP 2.12 2.03 1.58 1.65 1.92 1.41 1.37
Pkn2
KLA  ATP  ATP+KLA
 NM_178654 protein kinase N2 (Pkn2), mRNA [NM_178654] KLA 1.99 2.05 2.24 2.09 1.67 1.69 1.57
ATP 1.05 1.11 1.29 1.36 2.32 2.68 1.55
KLA/ATP 2.03 2.15 2.31 2.32 3.12 2.89 2.30
Pkn3
KLA  ATP  ATP+KLA
 AK154801 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630107C11 product:protein kinase N3, full insert sequence [AK154801] KLA 2.16 2.25 2.92 2.78 3.14 3.90 2.74
ATP 1.08 1.03 1.18 1.20 1.18 1.59 3.46
KLA/ATP 2.36 2.41 2.70 2.63 2.44 3.39 7.83
Pkn3
KLA  ATP  ATP+KLA
 NM_153805 protein kinase N3 (Pkn3), mRNA [NM_153805] KLA .82 .78 .76 .76 .73 .73 .68
ATP .96 1.06 1.04 1.01 .81 1.03 .78
KLA/ATP .84 .77 .81 .77 .76 .89 .76
Ppp2ca
KLA  ATP  ATP+KLA
 NM_019411 protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform (Ppp2ca), mRNA [NM_019411] KLA 1.17 1.13 1.18 1.20 1.54 1.45 1.34
ATP 1.09 1.20 1.07 1.33 1.56 2.04 1.43
KLA/ATP 1.14 1.17 1.15 1.49 1.59 2.37 2.02
Ppp2cb
KLA  ATP  ATP+KLA
 NM_017374 protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform (Ppp2cb), mRNA [NM_017374] KLA 1.32 1.33 1.37 1.24 1.27 1.09 1.18
ATP .94 .93 .82 .91 1.22 2.01 1.08
KLA/ATP 1.24 1.14 .80 .97 1.13 1.54 1.18
Ppp2r1a
KLA  ATP  ATP+KLA
 NM_016891 protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform (Ppp2r1a), mRNA [NM_016891] KLA 1.44 1.39 1.47 1.37 1.69 1.33 1.16
ATP 1.18 1.55 .85 1.67 1.38 .99 1.24
KLA/ATP 1.66 1.98 .97 2.33 1.41 1.65 1.38
Ppp2r1b
KLA  ATP  ATP+KLA
 NM_001034085 protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform (Ppp2r1b), transcript variant 1, mRNA [NM_001034085] KLA 1.26 1.17 1.14 1.13 1.12 1.11 .99
ATP .90 .90 .96 .98 1.59 1.71 1.16
KLA/ATP 1.23 1.16 .99 1.00 1.54 1.34 1.24
Ppp2r1b
KLA  ATP  ATP+KLA
 NM_028614 protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform (Ppp2r1b), transcript variant 2, mRNA [NM_028614] KLA 2.38 2.38 2.53 1.80 1.52 .95 1.16
ATP 1.17 1.29 1.04 1.09 1.16 1.19 1.00
KLA/ATP 2.59 2.78 1.82 2.31 1.34 1.03 .75
Ppp2r2a
KLA  ATP  ATP+KLA
 NM_028032 protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), alpha isoform (Ppp2r2a), mRNA [NM_028032] KLA 2.18 2.42 2.58 2.17 2.08 1.83 1.57
ATP 1.06 1.12 .90 1.28 1.76 1.70 1.39
KLA/ATP 2.55 2.38 1.62 2.68 2.25 2.55 1.86
Ppp2r2b
KLA  ATP  ATP+KLA
 AK086561 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930037C08 product:unclassifiable, full insert sequence [AK086561] KLA .94 1.02 1.07 1.02 1.02 .97 .98
ATP 1.01 1.04 1.01 .99 .97 .95 1.00
KLA/ATP 1.04 1.06 1.01 .96 1.02 .90 .93
Ppp2r2b
KLA  ATP  ATP+KLA
 NM_028392 protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), beta isoform (Ppp2r2b), transcript variant 2, mRNA [NM_028392] KLA 1.01 1.02 .96 1.00 1.04 1.01 1.00
ATP 1.00 .96 1.07 .93 .95 1.01 1.03
KLA/ATP .95 1.01 1.06 1.07 .98 1.02 1.03
Ppp2r2c
KLA  ATP  ATP+KLA
 NM_172994 protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform (Ppp2r2c), mRNA [NM_172994] KLA .97 .98 .96 1.02 1.02 1.06 1.01
ATP .96 1.05 1.03 .98 1.01 1.04 1.06
KLA/ATP .98 .98 1.00 .96 1.00 .86 1.10
Ppp2r2d
KLA  ATP  ATP+KLA
 NM_026391 protein phosphatase 2, regulatory subunit B, delta isoform (Ppp2r2d), mRNA [NM_026391] KLA 1.07 1.03 1.14 1.18 1.16 1.27 1.13
ATP .96 .93 .95 .76 1.34 2.21 1.22
KLA/ATP 1.01 1.01 1.01 .87 1.91 2.19 2.18
Ppp2r3a
KLA  ATP  ATP+KLA
 AK143212 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130310B05 product:protein phosphatase 2 (formerly 2A), regulatory subunit B, alpha, full insert sequence [AK143212] KLA 1.04 1.01 .92 1.16 1.08 1.09 1.04
ATP .98 .89 1.20 1.15 1.05 1.61 .79
KLA/ATP .95 .91 1.23 1.20 1.51 1.74 1.03
Ppp2r3c
KLA  ATP  ATP+KLA
 NM_021529 protein phosphatase 2, regulatory subunit B, gamma (Ppp2r3c), mRNA [NM_021529] KLA 1.19 1.21 1.28 1.45 1.35 1.38 1.59
ATP 1.02 .93 1.14 .95 .98 1.12 1.39
KLA/ATP 1.23 1.23 1.48 1.08 1.14 1.12 2.02
Ppp2r5a
KLA  ATP  ATP+KLA
 NM_144880 protein phosphatase 2, regulatory subunit B (B56), alpha isoform (Ppp2r5a), mRNA [NM_144880] KLA 3.55 3.70 4.28 3.81 3.87 2.52 1.55
ATP .99 1.00 .80 .82 1.04 1.62 1.41
KLA/ATP 3.48 3.79 2.82 2.77 2.16 2.02 2.43
Ppp2r5b
KLA  ATP  ATP+KLA
 NM_198168 protein phosphatase 2, regulatory subunit B (B56), beta isoform (Ppp2r5b), mRNA [NM_198168] KLA 1.12 1.20 1.13 1.18 1.13 .98 1.12
ATP .95 .98 .92 .98 .84 1.03 1.48
KLA/ATP 1.16 1.13 .88 .91 1.00 1.00 1.38
Ppp2r5c
KLA  ATP  ATP+KLA
 NM_012023 protein phosphatase 2, regulatory subunit B (B56), gamma isoform (Ppp2r5c), transcript variant 1, mRNA [NM_012023] KLA .80 .82 .82 .78 .88 1.07 1.27
ATP 1.07 1.11 1.09 1.14 .89 .64 1.07
KLA/ATP .87 .84 .77 .82 .73 .76 1.09
Ppp2r5d
KLA  ATP  ATP+KLA
 NM_009358 protein phosphatase 2, regulatory subunit B (B56), delta isoform (Ppp2r5d), mRNA [NM_009358] KLA .87 .86 .80 .75 .74 .77 .69
ATP .97 .96 1.05 1.10 1.00 .88 .62
KLA/ATP .91 .89 .84 .77 .79 .69 .59
Ppp2r5e
KLA  ATP  ATP+KLA
 NM_012024 protein phosphatase 2, regulatory subunit B (B56), epsilon isoform (Ppp2r5e), mRNA [NM_012024] KLA 1.07 1.09 1.12 1.14 1.11 1.11 1.15
ATP .99 .85 .92 .74 .76 1.23 1.30
KLA/ATP .99 .98 1.05 .77 .87 1.22 1.64
Prkaa1
KLA  ATP  ATP+KLA
 NM_001013367 protein kinase, AMP-activated, alpha 1 catalytic subunit (Prkaa1), mRNA [NM_001013367] KLA 1.10 1.03 1.17 1.25 1.24 1.61 2.29
ATP 1.04 1.07 1.10 1.08 1.04 2.01 2.13
KLA/ATP 1.07 1.04 1.04 1.17 .95 1.90 3.90
Prkaa2
KLA  ATP  ATP+KLA
 NM_178143 protein kinase, AMP-activated, alpha 2 catalytic subunit (Prkaa2), mRNA [NM_178143] KLA .93 .94 .94 .90 .92 .92 .99
ATP 1.00 1.14 .93 1.01 1.00 1.11 .98
KLA/ATP 1.00 .97 .99 1.01 .98 1.02 .98
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcz
KLA  ATP  ATP+KLA
 NM_008860 protein kinase C, zeta (Prkcz), transcript variant 1, mRNA [NM_008860] KLA .92 .90 1.00 .99 1.07 1.05 1.12
ATP 1.01 .95 .94 .93 1.04 1.04 .95
KLA/ATP .95 .94 .95 .94 .99 1.02 .98
Prl
KLA  ATP  ATP+KLA
 NM_011164 prolactin (Prl), mRNA [NM_011164] KLA 1.01 1.00 1.06 1.02 1.05 .96 .97
ATP .99 1.02 .97 .98 .97 .95 1.00
KLA/ATP 1.00 1.01 1.00 .97 .96 .87 .95
Prlr
KLA  ATP  ATP+KLA
 AK083198 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630026G18 product:unclassifiable, full insert sequence [AK083198] KLA .99 1.07 1.00 .95 1.01 .90 1.01
ATP 1.02 .94 .97 1.00 .97 .94 .96
KLA/ATP .98 .94 .96 .96 .99 1.07 1.02
Prlr
KLA  ATP  ATP+KLA
 AK087727 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330012C04 product:hypothetical protein, full insert sequence [AK087727] KLA 1.03 1.00 .99 1.01 1.02 1.04 .99
ATP 1.00 .95 1.13 1.06 .97 .98 1.04
KLA/ATP .97 1.01 .88 1.02 1.01 1.03 1.05
Prlr
KLA  ATP  ATP+KLA
 NM_011169 prolactin receptor (Prlr), mRNA [NM_011169] KLA .93 1.03 1.12 1.06 1.05 1.14 1.15
ATP .95 .99 1.11 1.13 1.06 1.19 1.18
KLA/ATP 1.02 1.01 1.05 1.10 1.10 1.21 1.07
Pten
KLA  ATP  ATP+KLA
 NM_008960 phosphatase and tensin homolog (Pten), mRNA [NM_008960] KLA .79 .73 .61 .59 .56 .70 1.00
ATP 1.04 1.11 1.07 1.12 1.03 1.38 .83
KLA/ATP .75 .69 .60 .74 .93 1.09 1.24
Ptk2
KLA  ATP  ATP+KLA
 NM_007982 PTK2 protein tyrosine kinase 2 (Ptk2), mRNA [NM_007982] KLA .99 .99 1.02 1.04 1.09 1.22 1.57
ATP 1.04 1.09 .95 .98 .67 .96 .87
KLA/ATP .99 1.03 .87 .93 .81 1.16 1.04
Rac1
KLA  ATP  ATP+KLA
 NM_009007 RAS-related C3 botulinum substrate 1 (Rac1), mRNA [NM_009007] KLA 1.02 1.01 1.02 .99 1.03 1.15 1.08
ATP .99 1.15 1.01 1.27 1.06 1.20 1.06
KLA/ATP 1.00 1.04 .88 1.16 .91 1.21 1.38
Raf1
KLA  ATP  ATP+KLA
 AK036317 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630056E02 product:v-raf-1 leukemia viral oncogene 1, full insert sequence. [AK036317] KLA 1.47 1.34 1.55 1.29 1.59 1.32 1.46
ATP 1.05 .98 .54 .63 3.32 2.07 1.01
KLA/ATP 1.57 1.33 .79 .96 2.26 1.38 1.35
Raf1
KLA  ATP  ATP+KLA
 NM_029780 v-raf-leukemia viral oncogene 1 (Raf1), mRNA [NM_029780] KLA 1.65 1.64 1.93 1.77 1.77 1.72 1.81
ATP .95 .96 .83 .80 2.22 2.92 1.19
KLA/ATP 1.68 1.64 1.39 1.32 1.85 2.50 2.06
Rbl2
KLA  ATP  ATP+KLA
 NM_011250 retinoblastoma-like 2 (Rbl2), mRNA [NM_011250] KLA .66 .69 .65 .51 .55 .57 .78
ATP 1.11 1.32 .95 1.14 .57 .47 .65
KLA/ATP .77 .76 .52 .64 .41 .52 .59
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Reln
KLA  ATP  ATP+KLA
 NM_011261 reelin (Reln), mRNA [NM_011261] KLA 1.00 1.00 .98 1.03 1.00 .99 .99
ATP 1.00 .99 1.05 1.08 1.01 .99 1.00
KLA/ATP 1.01 1.02 1.05 1.03 .98 .98 .98
Rheb
KLA  ATP  ATP+KLA
 NM_053075 RAS-homolog enriched in brain (Rheb), mRNA [NM_053075] KLA 1.03 1.00 .99 .99 .95 1.03 1.09
ATP .99 .89 .95 .81 1.07 1.19 .90
KLA/ATP 1.01 .87 .97 .82 1.06 1.22 .88
Rps6
KLA  ATP  ATP+KLA
 AK013825 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:2900086I01 product:ribosomal protein S6, full insert sequence. [AK013825] KLA 1.04 1.06 1.03 .99 .94 .96 1.26
ATP 1.01 1.00 1.04 .99 .99 .94 1.12
KLA/ATP 1.02 1.08 .95 1.04 .94 .97 .90
Rps6
KLA  ATP  ATP+KLA
 NM_009096 ribosomal protein S6 (Rps6), mRNA [NM_009096] KLA 1.01 1.01 .94 .87 .89 .66 .72
ATP 1.11 1.07 1.10 1.12 1.12 1.03 .47
KLA/ATP .96 1.04 1.22 1.10 .86 .84 .40
Rps6kb1
KLA  ATP  ATP+KLA
 NM_001114334 ribosomal protein S6 kinase, polypeptide 1 (Rps6kb1), transcript variant 1, mRNA [NM_001114334] KLA .99 1.00 .90 .89 .99 .99 .92
ATP 1.01 .96 1.00 .79 1.36 1.19 .72
KLA/ATP 1.08 .99 .93 .92 1.18 .90 .56
Rps6kb1
KLA  ATP  ATP+KLA
 NM_028259 ribosomal protein S6 kinase, polypeptide 1 (Rps6kb1), transcript variant 2, mRNA [NM_028259] KLA 1.01 .93 1.07 1.04 .99 .99 .98
ATP 1.09 1.05 1.00 1.01 1.08 1.03 1.03
KLA/ATP 1.07 1.04 .94 .98 1.03 1.05 1.05
Rps6kb2
KLA  ATP  ATP+KLA
 AK090093 kidney CCL-142 RAG cDNA, RIKEN full-length enriched library, clone:G430107K15 product:ribosomal protein S6 kinase, 70kD, polypeptide 2, full insert sequence [AK090093] KLA .97 1.01 .98 .97 .98 1.04 1.07
ATP 1.00 1.08 1.06 1.09 1.11 1.06 1.03
KLA/ATP 1.05 .96 .86 1.03 1.40 1.07 .99
Rps6kb2
KLA  ATP  ATP+KLA
 NM_021485 ribosomal protein S6 kinase, polypeptide 2 (Rps6kb2), mRNA [NM_021485] KLA 1.36 1.40 1.45 1.40 1.63 1.57 1.46
ATP 1.08 1.19 .97 1.15 .90 .99 1.34
KLA/ATP 1.44 1.55 1.09 1.39 1.00 1.12 1.77
Rxra
KLA  ATP  ATP+KLA
 NM_011305 retinoid X receptor alpha (Rxra), mRNA [NM_011305] KLA .53 .55 .50 .52 .54 .85 1.09
ATP .95 1.00 1.18 1.00 .82 1.20 1.65
KLA/ATP .57 .55 .58 .55 .67 1.07 1.57
Sgk1
KLA  ATP  ATP+KLA
 AK043284 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730081A20 product:unclassifiable, full insert sequence. [AK043284] KLA .94 1.04 1.04 1.00 .97 .96 1.03
ATP 1.08 .99 1.01 .96 1.00 .93 1.00
KLA/ATP .95 .95 1.02 .96 .97 1.00 .94
Sgk1
KLA  ATP  ATP+KLA
 NM_011361 serum/glucocorticoid regulated kinase 1 (Sgk1), mRNA [NM_011361] KLA 1.34 1.00 1.31 .82 1.31 2.97 2.62
ATP 1.05 1.05 3.10 12.21 20.68 7.13 1.80
KLA/ATP 1.31 1.17 2.98 10.32 15.03 6.81 4.65
Sgk2
KLA  ATP  ATP+KLA
 NM_013731 serum/glucocorticoid regulated kinase 2 (Sgk2), mRNA [NM_013731] KLA .98 1.05 .92 .98 .90 1.02 .97
ATP .99 .99 .98 .99 1.07 1.01 1.04
KLA/ATP .97 .96 .99 .95 1.10 1.00 1.03
Sgk3
KLA  ATP  ATP+KLA
 AK077817 adult male thymus cDNA, RIKEN full-length enriched library, clone:5832447I09 product:unclassifiable, full insert sequence. [AK077817] KLA 3.06 2.46 2.50 1.73 1.76 1.50 1.25
ATP 1.01 1.13 .96 .63 .81 .90 1.02
KLA/ATP 3.57 2.95 2.27 .95 1.08 .97 1.33
Sgk3
KLA  ATP  ATP+KLA
 AK083319 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:C920004G11 product:similar to PROTEIN KINASE (DJ138B7.2) (SERUM/GLUCOCORTICOID REGULATED KINASE 2) (SIMILAR TO SERUM/GLUCOCORTICOID REGULATED KINASE 2) [Hom KLA 1.00 1.02 1.01 1.05 .99 1.01 1.07
ATP 1.02 1.08 1.10 .97 .98 .96 .99
KLA/ATP 1.11 1.05 1.02 1.10 1.05 .96 .97
Sgk3
KLA  ATP  ATP+KLA
 NM_133220 serum/glucocorticoid regulated kinase 3 (Sgk3), transcript variant 1, mRNA [NM_133220] KLA 4.27 3.85 4.76 3.94 3.80 2.09 1.17
ATP 1.20 1.51 1.00 1.14 .61 .62 1.06
KLA/ATP 3.44 4.17 2.96 3.56 1.43 .84 1.36
Sos1
KLA  ATP  ATP+KLA
 NM_009231 Son of sevenless homolog 1 (Drosophila) (Sos1), mRNA [NM_009231] KLA 2.36 2.40 3.42 3.15 2.78 1.81 1.71
ATP .99 1.00 .99 1.15 1.14 1.25 1.24
KLA/ATP 2.41 2.26 1.95 2.44 1.47 1.66 1.37
Sos2
KLA  ATP  ATP+KLA
 XM_127051 gb|PREDICTED: Mus musculus Son of sevenless homolog 2 (Drosophila) (Sos2), mRNA [XM_127051] KLA .81 .77 .79 .92 1.04 1.06 1.20
ATP 1.00 1.00 1.09 .79 .68 .81 .94
KLA/ATP .77 .69 .71 .60 .64 .77 1.07
Spp1
KLA  ATP  ATP+KLA
 NM_009263 secreted phosphoprotein 1 (Spp1), mRNA [NM_009263] KLA 1.41 1.62 1.39 1.31 1.31 1.00 .51
ATP 1.08 1.21 1.49 1.79 2.55 3.51 3.41
KLA/ATP 1.40 1.54 1.51 1.43 2.01 3.18 2.46
Syk
KLA  ATP  ATP+KLA
 NM_011518 spleen tyrosine kinase (Syk), mRNA [NM_011518] KLA 2.48 2.59 2.57 2.26 3.29 3.75 3.19
ATP .96 .85 .59 1.01 2.80 3.77 2.11
KLA/ATP 2.56 2.09 1.16 1.35 2.50 4.33 5.10
Tcl1
KLA  ATP  ATP+KLA
 NM_009337 T-cell lymphoma breakpoint 1 (Tcl1), mRNA [NM_009337] KLA 1.04 1.05 1.03 1.02 1.09 1.07 1.03
ATP .96 1.00 1.10 1.21 1.14 1.20 1.06
KLA/ATP 1.00 1.04 1.07 1.48 1.32 1.29 1.10
Tcl1b1
KLA  ATP  ATP+KLA
 NM_013773 T-cell leukemia/lymphoma 1B, 1 (Tcl1b1), mRNA [NM_013773] KLA .86 1.03 1.06 1.08 .98 1.02 1.13
ATP 1.01 .98 1.00 1.04 1.03 1.04 1.01
KLA/ATP 1.07 1.06 1.02 1.08 1.08 1.14 1.02
Tcl1b4
KLA  ATP  ATP+KLA
 NM_013774 T-cell leukemia/lymphoma 1B, 4 (Tcl1b4), mRNA [NM_013774] KLA 1.16 1.10 1.19 1.10 1.15 1.21 1.13
ATP 1.02 .99 .98 .95 1.00 1.16 1.08
KLA/ATP 1.02 1.07 1.10 1.05 1.11 1.19 1.17
Tek
KLA  ATP  ATP+KLA
 AK053336 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130010K24 product:endothelial-specific receptor tyrosine kinase, full insert sequence. [AK053336] KLA .93 .98 .93 .90 .96 1.01 1.10
ATP 1.01 .97 .93 .99 .91 .98 .99
KLA/ATP 1.02 1.06 .95 .93 .92 .91 .92
Tek
KLA  ATP  ATP+KLA
 NM_013690 endothelial-specific receptor tyrosine kinase (Tek), mRNA [NM_013690] KLA 1.00 .95 1.02 .93 .98 .97 1.06
ATP 1.05 1.07 1.01 1.05 .98 1.08 1.13
KLA/ATP .94 .96 1.03 1.11 1.15 .99 1.25
Thbs1
KLA  ATP  ATP+KLA
 NM_011580 thrombospondin 1 (Thbs1), mRNA [NM_011580] KLA 2.22 2.22 2.74 3.10 4.57 7.17 7.22
ATP 1.16 2.53 8.45 12.26 15.50 43.06 35.83
KLA/ATP 2.46 3.43 8.29 17.50 28.16 46.17 54.67
Thbs2
KLA  ATP  ATP+KLA
 NM_011581 thrombospondin 2 (Thbs2), mRNA [NM_011581] KLA .99 1.03 1.04 1.03 1.04 1.17 1.03
ATP 1.01 1.04 1.01 1.02 .98 1.03 .97
KLA/ATP 1.08 1.04 .95 1.05 1.15 1.14 1.04
Thbs3
KLA  ATP  ATP+KLA
 NM_013691 thrombospondin 3 (Thbs3), mRNA [NM_013691] KLA .86 .93 .86 .95 .90 .79 .79
ATP 1.06 1.02 1.11 1.10 .96 1.03 1.07
KLA/ATP .90 .88 .92 .92 .98 .96 .98
Thbs4
KLA  ATP  ATP+KLA
 NM_011582 thrombospondin 4 (Thbs4), mRNA [NM_011582] KLA 1.16 1.13 1.19 1.13 1.13 1.16 1.07
ATP 1.00 1.14 1.07 .99 1.07 1.25 1.10
KLA/ATP 1.16 1.18 1.24 1.55 1.55 1.94 1.48
Them4
KLA  ATP  ATP+KLA
 AK014834 adult male testis cDNA, RIKEN full-length enriched library, clone:4921507I02 product:weakly similar to C-TERMINAL MODULATOR PROTEIN [Homo sapiens], full insert sequence [AK014834] KLA .89 .99 1.02 .94 .87 1.01 1.07
ATP .99 .98 .89 .95 .96 .91 .96
KLA/ATP .94 .99 1.00 .88 .94 .94 .94
Them4
KLA  ATP  ATP+KLA
 NM_029431 thioesterase superfamily member 4 (Them4), mRNA [NM_029431] KLA 1.07 1.10 1.13 1.32 1.28 1.43 1.56
ATP .93 .91 1.20 1.09 .84 1.36 1.34
KLA/ATP 1.00 1.07 1.20 1.14 1.00 1.42 1.11
Tlr2
KLA  ATP  ATP+KLA
 NM_011905 toll-like receptor 2 (Tlr2), mRNA [NM_011905] KLA 13.65 11.82 8.87 7.95 4.67 2.78 2.33
ATP 1.06 1.24 2.76 6.28 11.55 13.82 .67
KLA/ATP 13.11 12.91 14.48 13.84 14.18 11.14 2.78
Tlr4
KLA  ATP  ATP+KLA
 NM_021297 toll-like receptor 4 (Tlr4), mRNA [NM_021297] KLA .69 .61 .75 .94 .64 .81 .73
ATP .95 .90 1.12 .56 .47 1.51 1.53
KLA/ATP .57 .62 1.01 .64 .39 .73 1.13
Tnc
KLA  ATP  ATP+KLA
 AK048765 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230053B09 product:tenascin C, full insert sequence. [AK048765] KLA 1.22 1.24 1.38 1.04 .98 1.03 1.03
ATP 1.01 1.04 1.02 1.08 .99 1.04 1.04
KLA/ATP 1.28 1.36 1.19 1.05 1.03 1.06 1.04
Tnc
KLA  ATP  ATP+KLA
 NM_011607 tenascin C (Tnc), mRNA [NM_011607] KLA 1.41 1.56 1.78 1.51 1.60 1.33 1.01
ATP 1.05 1.05 1.05 1.18 1.03 1.24 1.11
KLA/ATP 1.46 1.74 1.63 1.64 1.29 1.26 1.12
Tnn
KLA  ATP  ATP+KLA
 NM_177839 tenascin N (Tnn), mRNA [NM_177839] KLA 1.62 1.81 1.88 1.81 1.51 1.28 1.02
ATP 1.00 1.12 1.10 1.04 1.05 1.18 1.02
KLA/ATP 1.79 1.82 1.73 1.57 1.32 1.13 1.12
Tnr
KLA  ATP  ATP+KLA
 NM_022312 tenascin R (Tnr), mRNA [NM_022312] KLA .98 .94 1.01 1.02 .96 .98 .94
ATP 1.08 .97 1.00 .95 1.01 .89 1.10
KLA/ATP .98 1.03 1.00 .97 .94 .91 1.03
Tnxb
KLA  ATP  ATP+KLA
 NM_031176 tenascin XB (Tnxb), mRNA [NM_031176] KLA 1.02 .95 1.00 .96 .97 .99 .98
ATP .99 1.02 1.00 1.02 1.00 .98 1.01
KLA/ATP .99 1.04 1.01 .95 .99 .95 .97
Trp53
KLA  ATP  ATP+KLA
 NM_011640 transformation related protein 53 (Trp53), mRNA [NM_011640] KLA 1.25 1.37 1.11 .86 .72 .71 .95
ATP 1.15 1.32 .90 1.85 1.26 .68 .70
KLA/ATP 1.66 1.49 .80 1.76 .81 .65 .74
Tsc1
KLA  ATP  ATP+KLA
 AK083363 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:C920023H23 product:tuberous sclerosis 1, full insert sequence. [AK083363] KLA .69 .66 .60 .71 .85 .78 .77
ATP 1.13 1.26 1.70 2.23 1.77 .87 .90
KLA/ATP .76 .77 .90 1.19 1.74 .80 .72
Tsc1
KLA  ATP  ATP+KLA
 NM_022887 tuberous sclerosis 1 (Tsc1), mRNA [NM_022887] KLA .93 .94 1.00 1.04 1.01 .95 1.10
ATP 1.12 1.10 1.12 1.27 1.66 1.45 1.80
KLA/ATP .95 1.00 1.06 1.03 1.26 1.30 1.74
Tsc2
KLA  ATP  ATP+KLA
 NM_011647 tuberous sclerosis 2 (Tsc2), transcript variant 1, mRNA [NM_011647] KLA .91 .88 .87 .83 .83 .88 .99
ATP .91 .91 1.04 .88 .76 .68 .91
KLA/ATP .88 .89 .88 .76 .65 .67 .85
Vegfa
KLA  ATP  ATP+KLA
 NM_001025250 vascular endothelial growth factor A (Vegfa), transcript variant 1, mRNA [NM_001025250] KLA .49 .48 .46 .46 .39 .64 1.18
ATP 1.05 1.37 3.82 10.55 12.51 24.20 7.85
KLA/ATP .48 .59 1.45 7.42 19.75 27.42 22.35
Vegfa
KLA  ATP  ATP+KLA
 NM_001025257 vascular endothelial growth factor A (Vegfa), transcript variant 3, mRNA [NM_001025257] KLA .72 .71 .66 .70 .65 .80 1.22
ATP 1.01 1.21 3.24 11.12 11.09 18.59 5.43
KLA/ATP .68 .71 1.47 5.94 15.06 20.32 17.31
Vegfb
KLA  ATP  ATP+KLA
 NM_011697 vascular endothelial growth factor B (Vegfb), mRNA [NM_011697] KLA .65 .63 .65 .63 .52 .38 .37
ATP 1.11 1.07 1.16 1.44 1.72 1.22 .43
KLA/ATP .67 .67 .89 .90 1.19 .86 .31
Vegfc
KLA  ATP  ATP+KLA
 NM_009506 vascular endothelial growth factor C (Vegfc), mRNA [NM_009506] KLA 2.07 2.21 2.04 3.27 2.51 1.73 2.90
ATP 1.08 1.03 1.24 1.32 2.55 5.18 2.58
KLA/ATP 2.20 2.29 2.72 2.97 4.35 4.24 5.06
Vtn
KLA  ATP  ATP+KLA
 NM_011707 vitronectin (Vtn), mRNA [NM_011707] KLA 1.05 1.05 1.01 1.00 .97 1.04 .95
ATP .94 .99 1.00 .94 .96 1.04 1.09
KLA/ATP .97 1.00 1.02 .99 .98 .94 .98
Vwf
KLA  ATP  ATP+KLA
 AK044921 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130011O06 product:VON WILLEBRAND FACTOR (FRAGMENT) homolog [Saguinus bicolor], full insert sequence. [AK044921] KLA 1.02 .96 .97 .95 .97 1.00 .91
ATP 1.01 1.03 .93 1.02 1.01 1.00 1.08
KLA/ATP .99 .93 .99 .96 1.02 1.01 1.08
Vwf
KLA  ATP  ATP+KLA
 NM_011708 Von Willebrand factor homolog (Vwf), mRNA [NM_011708] KLA .56 .56 .51 .41 .37 .50 .33
ATP 1.09 .99 .77 .88 3.26 2.28 .64
KLA/ATP .65 .58 .46 .52 2.61 3.48 1.38
Ywhab
KLA  ATP  ATP+KLA
 NM_018753 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide (Ywhab), mRNA [NM_018753] KLA 1.03 1.15 1.18 1.10 1.20 1.20 1.23
ATP 1.02 1.08 .84 1.06 1.08 1.24 1.24
KLA/ATP 1.15 1.18 .82 1.17 .91 1.24 1.58
Ywhae
KLA  ATP  ATP+KLA
 NM_009536 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide (Ywhae), mRNA [NM_009536] KLA 1.32 1.35 1.43 1.40 1.46 1.45 1.19
ATP 1.09 1.30 1.21 1.51 1.16 .97 1.01
KLA/ATP 1.45 1.50 1.33 1.85 1.25 1.16 1.08
Ywhag
KLA  ATP  ATP+KLA
 NM_018871 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide (Ywhag), mRNA [NM_018871] KLA .87 .96 .92 .89 1.14 1.30 1.77
ATP 1.08 1.22 .86 .83 .91 1.46 1.09
KLA/ATP 1.05 1.04 .61 .72 .76 1.44 1.52
Ywhah
KLA  ATP  ATP+KLA
 NM_011738 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide (Ywhah), mRNA [NM_011738] KLA .55 .54 .49 .44 .38 .58 .70
ATP .99 .93 1.14 .81 .62 .53 1.07
KLA/ATP .54 .52 .54 .35 .37 .35 .68
Ywhaq
KLA  ATP  ATP+KLA
 AK037746 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130046D12 product:unclassifiable, full insert sequence [AK037746] KLA .97 .93 .94 .95 .97 .96 .95
ATP 1.09 1.07 1.44 1.49 1.04 1.01 .96
KLA/ATP 1.04 .96 1.11 1.36 1.01 1.03 .87
Ywhaq
KLA  ATP  ATP+KLA
 NM_011739 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide (Ywhaq), mRNA [NM_011739] KLA .93 .98 .96 .99 .92 .76 .88
ATP 1.07 1.08 1.01 1.35 1.37 1.28 .70
KLA/ATP .97 1.04 .94 1.17 1.09 1.18 .77
Ywhaz
KLA  ATP  ATP+KLA
 AK050511 adult pancreas islet cells cDNA, RIKEN full-length enriched library, clone:C820005J08 product:tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide, full insert sequence. [AK050511] KLA .99 .96 .97 .96 1.00 .95 .96
ATP .99 1.00 .98 1.01 1.04 .94 1.01
KLA/ATP .99 .97 1.00 .98 .88 .97 1.01
Ywhaz
KLA  ATP  ATP+KLA
 NM_011740 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (Ywhaz), mRNA [NM_011740] KLA 1.79 1.86 1.98 2.10 2.11 2.10 1.30
ATP 1.00 1.21 .95 1.37 1.21 1.42 1.08
KLA/ATP 1.73 1.92 1.58 2.28 1.68 1.76 1.47